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Abstract 
Purpose: To establish whether a bout of hypoxic preconditioning (HPC) or 
ischemic preconditioning (IPC) would elicit a reduction in total knee replacement 
(TKR) surgery specific tourniquet mediated oxidative stress (OS) in-vivo. 
Methods: In an independent group design, 18 healthy men were exposed to 40 min 
of either: whole-body HPC (14.3% O2), IPC (four bouts of 5 min ischemia and 5 
min reperfusion) or rest (SHAM), 1 h prior to 30 min TKR specific limb ischemia 
and 2 h reperfusion. Systemic blood samples were taken at pre- and post-
intervention, additionally blood and gastrocnemius samples were obtained at pre-, 
15 min post- (15PoT) and 120 min post-tourniquet deflation. Systemic leukocytes 
and gastrocnemius tissue were analysed for the heat shock protein (Hsp72) and 
Heat shock protein 32 (Hsp32) gene transcript response (indicates severity of the 
cellular stress response), with the systemic plasma also assessed for OS markers 
(protein carbonyl and glutathione (reduced, oxidised, total, reduced/oxidised-
ratio)). Results: A 1.93 and 1.97 fold reduction in gastrocnemius Hsp72 was noted 
in individuals exposed to HPC (p = 0.007) and IPC (p = 0.006) respectively, in 
comparison to SHAM at 15PoT. No significant differences were observed in 
gastrocnemius Hsp32, systemic Hsp72, Hsp32 or OS markers (p > 0.05) between 
groups. Conclusions: HPC and IPC provided cytoprotection to ischemic stressed 
gastrocnemius tissue as indicated by an attenuated cellular stress response to 30 
min TKR specific limb ischemia.  
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1.1 General Introduction 
Maintenance of homeostasis is paramount in the human body. This delicate 
balance is essential for efficient cellular function and survival of the body as a 
whole (Tortora and Grabowski, 1996). Stressful situations invoke disruption to the 
redox balance via a sharp increase in reactive oxygen species (ROS), diminishing 
endogenous antioxidants (such as the glutathione, MnSOD), thus instigating 
oxidative stress (Halliwell and Gutteridge, 2007). Although excess ROS induces 
oxidative stress and has been correlated with many disease states, low 
concentrations of ROS are essential for routine cellular signalling (Ray et al., 
2012).          
Tourniquets are widely used during total knee replacement (TKR) surgery to 
provide a bloodless field, improving visualisation of crucial structures and 
accelerating the surgical procedure (Smith and Hing, 2010; Estebe et al., 2011). 
Tourniquets have been used by medical practitioners since ancient Roman times 
(Klenerman, 1962), but there had been very little advancement in their design 
until the early 20
th
 century when Harvey Cushing employed a pneumatic 
tourniquet system to limit bleeding during a craniotomy procedure (Fletcher and 
Healy, 1983). Nevertheless, there are negative features associated with the 
application of tourniquets, including, delayed wound healing, vascular injury and 
muscular damage (Estebe et al., 2011; Fitzgibbons et al., 2012), inviting 
controversy with regards to their use. In fact, delayed wound healing has been 
cited to defer patient discharge, incurring greater financial costs to the healthcare 
provider (Drew et al., 2007).    
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TKR surgery can last from (mean ± SD) 79.9 ± 12.7 min (Chang et al., 2012) to 
145 ± 25 min (Horlocker et al., 2006) during which time a tourniquet is inflated. 
The interruption of blood supply mediated by the tourniquet, induces a hypoxic 
environment in the distal tissue (Clarke et al., 2001). Long periods of ischemia 
inhibit the regeneration of adenosine triphosphate (ATP) through aerobic sources, 
placing greater demands on the anaerobic glycolytic pathway (Ostman et al., 
2004). The demand for ATP exceeds its replenishment leading to eventual 
adenine nucleotide degradation to produce the purine bases hypoxanthine and 
xanthine (Jennings and Reimer, 1991). 
Upon reperfusion, the influx of oxygen initiates a rapid production of ROS via 
activated leukocytes, enzymatic degradation of purine bases and disruption of the 
vital mitochondrial electron transport chain (Granger et al., 1986; Carden and 
Granger, 2000; Murphy and Steenbergen, 2008). The large influx of ROS 
subsequently overwhelms the endogenous antioxidant defence systems 
stimulating oxidative stress (Adachi et al., 2006). Consequentially, triggering 
macromolecule damage to enzymatic structures, cellular lipid membranes and 
deoxyribonucleic acid (DNA) (Adachi et al., 2006; Ray et al., 2012; Brierley and 
Martin, 2013), thus inducing eventual cellular apoptosis and necrosis to the 
localised tissue (Jaeschke and Lemasters, 2003). This cascade of events has been 
dubbed ischemia reperfusion injury (IRI).    
To diminish IRI, many agents and techniques have been applied, including 
administration of exogenous antioxidants such as, curcumin (Avci et al., 2012), 
caffeic acid (Ozyurt et al., 2006) and edaravone (Hori et al., 2013). Interestingly, 
the use of short cycles of ischemia and reperfusion primed the intended tissue and 
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bestowed protection for future ischemic insults (Murry et al., 1986). This 
phenomenon was termed ischemic preconditioning (IPC) and has been 
demonstrated to provide protection from IRI in both animal models (Mayr et al., 
2004) and human participants (Koca et al., 2011). It is proposed that IPC operates 
in a biphasic modus through the activation of protein kinases, heat shock proteins 
(HSPs), de novo protein synthesis and stimulated transcription factors (Das and 
Das, 2008).  
Various animal studies have used hypoxic stress as a preconditioning mediator to 
induce similar effects to IPC (Xi et al., 2002; Berger et al., 2010). It has also been 
demonstrated that consecutive whole-body hypoxic exposures attenuate the 
disruption to the redox balance caused by aerobic exercise in humans (Taylor et 
al., 2012). Indeed, hypoxic preconditioning (HPC) has been cited to function 
through similar mechanisms to IPC (Zuo et al., 2013). However, very few studies 
have investigated the effects of HPC on IRI in human skeletal muscle in vivo. 
Since HPC offers protection from redox balance disturbances (Taylor et al., 2012) 
and induces similar effects as IPC in animal models (Berger et al., 2010), it is 
therefore inferred that HPC would mitigate IRI in human skeletal muscle. 
Considering that approximately 153,000 TKR operations were performed in 
England and Wales between 2008 and 2010 (Baker et al., 2013) costing on 
average £7500 (Dakin et al., 2012), the majority of the financial costs associated 
with TKR are incurred following the surgery via patient length of stay (Smith et 
al., 2008). Therefore, potential interventions to lessen tourniquet mediated tissue 
damage and delayed wound healing are crucial to reducing the length of stay and 
thus the financial burden upon health service providers.  
5 
 
1.2 Aims and Objectives       
 
This thesis proposes to: 
1) Quantify the time course for redox disturbances to the systemic and 
localised circulation via analysis of protein carbonyl (PC), reduced 
glutathione (GSH), oxidised glutathione (GSSG) and total glutathione 
(TGH), following hypoxic and ischemic preconditioning, in addition to 
immediately and 2 hrs succeeding tourniquet mediated ischemia.   
2) Examine the time course for changes in Hsp72 and Hsp32 in localised 
skeletal muscle, in addition to localised and systemic leukocytes utilising 
the same time points as outlined in 1).     
3) Evaluate the efficacy of both whole-body HPC and limb IPC based on the 
observed changes in 1) and 2) from TKR specific tourniquet application. 
It was therefore hypothesised that: 
 IPC and HPC would demonstrate a lower expression of Hsp72 in the 
localised muscle tissue (gastrocnemius) in comparison to control following 
TKR specific tourniquet application. 
 Localised muscle Hsp32 would increase in HPC and IPC following 
tourniquet ischemia stress when compared to control.  
 The systemic and localised circulatory redox markers (GSSG, PC) and 
stress protein expression (Hsp72 and Hsp32) would increase from the 
subsequent bout of TKR tourniquet application in the control condition in 
comparison to both HPC and IPC. 
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This thesis is not a technical surgical paper, as such, will not contain novel 
operative procedures. The subsequent review will encompass a broad surmise of 
the major free radical species and the foremost antioxidant defence system, 
glutathione, in relation to the disturbed redox induced by the free radical entities. 
In addition, it will portray a logical progression of the events generated by the 
counter-intuitive phenomenon, IRI. Finally, the mechanisms responsible for 
potential preconditioning techniques will be explored, with particular interest 
focused upon the cytoprotective protein family, HSPs. 
It should be noted that although this thesis concentrates on the negative effects of 
ROS, a large body of evidence is available suggesting the role free radicals play in 
hormesis (Nikolaidis et al., 2013) and normal cellular signalling, in both muscle 
(Powers et al., 2010a) and blood (Nikolaidis and Jamurtas, 2009).                
The heart, kidney, liver and brain have been the most frequently studied within 
IRI due to the mortality rates associated with the failure of these organs. 
Therefore, the subsequent review has attempted to locate research concerning 
skeletal muscle, however research on other tissue has been utilised to demonstrate 
the point in question if skeletal muscle data is unobtainable.          
2.1 Preoperative phase 
TKR is an established treatment to alleviate the pain and discomfort associated 
with knee osteoarthritis as well as improving quality of life (Woolhead et al., 
2005). Previous TKR studies have shown a mean length of stay of between 7.6 – 
13.4 days (Rissanen et al., 1996; Smith et al., 2008; Jonas et al., 2013), which can 
be influenced through a variety of patient (social depravity, age, gender) and 
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hospital (peri-operative analgesia and care, recovery programmes) factors (Jonas 
et al., 2013). Reduced length of stay has been shown to be positively associated 
with increased patient satisfaction (Husted et al., 2008). To obtain patient insight 
with regards to the success of the TKR surgery, the Oxford Knee Score was 
developed, as potentially patients’ perception of a satisfied outcome may differ 
from that of the surgeon (Dawson et al., 1998). Oxford Knee Score is specific to 
TKR surgery, with questions relating to pain and everyday movements rather than 
clinical and radiological data (Dawson et al., 1998).  
There is vast pressure in the current economic climate to diminish National Health 
Service expenditure, particularly via cutting expenses (Dakin et al., 2012). 
Recently, research has attempted to establish early recovery programmes 
following TKR in an attempt to reduce hospital length of stay, with 
implementation demonstrating partial success (Smith et al., 2012). However, TKR 
often involves the routine application of a tourniquet to provide a bloodless field 
and improve visualisation of structures, thus reducing operative times 
(Abdelsalam and Eyres, 1995; Memtsoudis et al., 2010). Consequently, the 
occluded blood supply induces a hypoxic environment to the distal tissue (Clarke 
et al., 2001), increasing the risk of deleterious effects such as nerve palsy, 
metabolic disturbances, muscular injury and IRI (Fitzgibbons et al., 2012). The 
combination of these negative effects could perhaps explain the delayed discharge 
from hospitals noted in tourniquet versus non-tourniquet studies (Estebe et al., 
2011).   
Thus to maintain the advantages of tourniquet use (site structure clarity, reduced 
operative time) but attempt to minimise the associated deleterious effects, a 
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preconditioning intervention could be utilised. Therefore, it is necessary to 
establish homeostatic molecular events in order to comprehend the contrasting 
circumstances that occur through tourniquet mediated ischemia.             
2.1.1 Redox Homeostasis 
Prior to surgery in healthy individuals, redox homeostasis is maintained via an 
array of endogenous and exogenous antioxidant defence systems combating 
excessive pro-oxidant RONS (reactive oxygen and nitrogen species) (Halliwell 
and Gutteridge, 2007). At rest, the continuous production of RONS are associated 
with normal cellular metabolism (Valko et al., 2007). However, an increased 
production of pro-oxidants and concomitant failure of the anti-oxidant defence 
system initiates oxidative stress (Halliwell and Gutteridge, 2007). In this thesis, 
oxidative stress will be defined as; a disturbance to the redox balance in favour of 
ROS, leading to potential damage (Halliwell and Whiteman, 2004).  
Below is a concise description of the major ROS produced by skeletal muscle 
tissue, the source of these radicals and their associated interactions with cellular 
components.    
 
 
2.1.2 Free Radicals 
Superoxide Anion  
Superoxide (O2
•-
) is produced through the transfer of an electron to the base-state 
oxygen atom, generally occurring in the “leaky” sites of the mitochondria electron 
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transport chain or from enzymatic reactions within the cell (Powers et al., 2010a). 
O2
•-
 is considered a fairly weak ROS in comparison to others mentioned 
subsequently (Halliwell and Gutteridge, 2007), however, although the radical 
itself may not react directly, it can induce more potent species through its 
conversion (Figure 2.1) and has a relatively long half-life in comparison to other 
species (Halliwell, 1999; Powers and Jackson, 2008). Of note is the dismutation 
of O2
•- 
through enzymatic (manganese superoxide dismutases) and spontaneous 
reactions providing a key source of hydrogen peroxide (H2O2) (Powers and 
Jackson, 2008).   
 
Figure 2.1: Mechanisms of the superoxide anion in initiating damage through its 
conversion. Abbreviations: O2
•-
 - superoxide; H2O2 - hydrogen peroxide; OH
•
 - 
hydroxyl radical; HO2
•
 - protonated superoxide anion; NO
•
 - nitric oxide; ONOO
-
 
- peroxynitrite; HP - heme proteins; Cp - caeruplasmin. Diagram taken from 
Halliwell (1999). 
Hydroxyl Radical  
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Hydroxyl radicals (OH
•
) are highly reactive and due to this, are not membrane 
permeable, often reacting immediately with the surrounding environment. The 
majority of OH
• 
formed are transpired through Fenton chemistry of H2O2 
catalysed by free heme (Halliwell, 1995). Indeed, research has demonstrated that 
the majority of the damage to DNA in cells treated with H2O2 is caused by OH
• 
(Spencer et al., 1995).      
Hydrogen Peroxide 
H2O2 is a relatively weak stable oxidising agent, however, it can permeate cell 
membranes and is readily produced, not just through dismutation of O2
•- 
(Powers 
and Jackson, 2008) as mentioned previously, but also via other enzymatic 
reactions including xanthine oxidase (XO) (Sachdev and Davies, 2008). Although 
not very reactive, H2O2 is capable of inactivating certain enzymes directly, 
including the glycolytic enzyme GAPDH (Glyceraldehyde 3-phosphate 
dehydrogenase) (Halliwell and Gutteridge, 2007) and is the main source of OH
• 
as 
mentioned previously. 
Nitric Oxide (NO) 
Nitric oxide (NO) is soluble in both water and lipids and has an array of biological 
roles including, vasodilation, neurotransmission and inhibition of platelet 
aggregation (Love, 1999). It is mainly synthesised through the conversion of L-
arginine catalysed by the enzyme nitric oxide synthase (Powers and Jackson, 
2008). Although not a reactive free radical, NO reacts readily with O2
•-
 to form the 
reactive nitrogen specie, peroxynitrite (ONOO
-
), which can lead to the production 
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of other damaging species (Brown and Borutaite, 2002). NO will react 
preferentially with other radicals and heme groups (Ferrer-Sueta and Radi, 2009).   
Peroxynitrite      
  
ONOO
-
 is biologically generated through the reaction between O2
•-
 and NO 
(Ferrer-Sueta and Radi, 2009). Although ONOO
-
 is fairly stable, it is a strong 
oxidant, which reacts slowly with biological molecules, therefore largely 
influencing biological reactions within cells (Pacher et al., 2007). Upon pronation, 
ONOO- is converted to peroxynitrous acid which is extremely reactive and yields 
further oxidising and nitrating species (Arteel et al., 1999).  
The production of RONS are imperative to correct regulation of wound healing 
(Sen, 2003). However, an accumulation of excess RONS leads to oxidative stress 
and eventual impairment in wound healing (Soneja et al., 2005). Therefore, it is 
inferred that oxidative stress produced via tourniquet inflation during TKR 
operations would negatively affect wound healing following surgery. Fortunately, 
the body has the ability to negate excessive pro-oxidants and maintain redox 
homeostasis via an antioxidant defence system.     
2.1.3 Antioxidant defences   
 
The body has a multitude of antioxidant defence systems to defend against 
cellular free radical disruption. Endogenous systems include the enzymes 
glutathione reductase, catalase and  superoxide dismutase among others 
(Halliwell, 1999). In addition, exogenous sources that are gained through dietary 
intake such as vitamin C and E also supplement the antioxidant defence 
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(Halliwell, 1999). However, detail descriptions of these are not in the scope of this 
thesis. Accordingly, following the account above, the subsequent section will 
provide a thorough description of the antioxidant system glutathione as this 
particular marker was assessed during the experimental trial.              
2.1.3.1 Glutathione 
 
Glutathione is the most abundant non-protein thiol found in animal cells which is 
synthesised exclusively in the cytosol and is distributed throughout intracellular 
organelles including the nucleus, mitochondria and the endoplasmic reticulum 
(Mari et al., 2013). Intracellular glutathione is predominantly found as GSH, 
accounting for around 99% of the TGH found in the majority of human tissue 
(Halliwell and Gutteridge, 2007). Degradation of GSH to its oxidised form 
(GSSG) occurs exclusively in extracellular spaces, thus involving membrane 
transporters to deliver glutathione to different organelles or extracellular spaces 
(Ballatori et al., 2009). The biosynthesis of glutathione involves glutamate, 
cysteine and glycine through the enzymatic action of glutamate cysteine ligase 
and glutathione synthase (Figure 2.2) (Maher, 2005). GSH can neutralise H2O2 
either through enzymatic (glutathione peroxidase) or non-enzymatic reactions 
generating GSSG, which is then available to be recycled back into GSH to aid 
further in cellular protection (Figure 2.2) (Maher, 2005; Halliwell and Gutteridge, 
2007). 
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Figure 2.2: Glutathione synthesis and metabolism pathways. Abbreviations: GSH 
– reduced glutathione; GSSG - oxidised glutathione; NADPH – reduced 
nicotinamide adenine dinucleotide phosphate; NADP – nicotinamide adenine 
dinucleotide phosphate; H2O2 – hypdrogen peroxide; H2O – water. Adapted from 
Maher (2005). 
 
Glutathione is often measured in whole blood samples due to the low 
concentration of TGH found in plasma (0.5%) and vast levels in erythrocytes 
(99.5%) (Serru et al., 2001). It has been previously used in varying protocols to 
assess oxidative stress in hypoxia (Taylor et al., 2012), dehydration (Hillman et 
al., 2011) and ageing (Jones et al., 2002) among others.  
Glutamate + Cysteine 
Glutamate Cysteine Ligase 
γ-glutamyl-cysteine 
Glutathione Synthase 
GSH 
GSSG NADP 
NADPH H2O 
H2O2 
Glycine 
Glutathione Peroxidase Glutathione Reductase 
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The attenuation of GSH has been associated with delayed wound healing (Rasik 
and Shukla, 2000), therefore, monitoring concentrations of this tripeptide would 
provide useful when assessing tourniquet mediated redox disturbances.   
Multiple methods are available to analyse glutathione samples from human blood 
and muscle tissue (Rahman et al., 2006), the choice made regarding the presented 
thesis is detailed in section 3.9. 
2.1.4 Cellular Damage  
If the antioxidant defence systems are overwhelmed oxidative stress will ensue 
(Halliwell and Gutteridge, 2007). Excessive cellular damage of lipids, proteins 
and DNA following oxidative stress is common in delayed wound healing (Soneja 
et al., 2005). Below is a general description of the mechanisms that produce lipid 
peroxidation, protein oxidation and DNA damage following oxidative stress. 
2.1.4.1 Lipid Peroxidation 
Free radicals induce structural changes to cellular membranes, affecting their 
functional capacity, thus allowing more direct free radical attacks upon 
intracellular proteins (Halliwell and Chirico, 1993). In addition, lipid peroxidation 
(LP) increases membrane permeability to ions, giving rise to intracellular 
increases of Ca
2+
 inducing disruptions to cellular metabolism (Halliwell and 
Chirico, 1993; Niki, 2008). 
Radical mediated peroxidation mechanisms involve the removal of protons from 
polyunsaturated fatty acids to produce a lipid radical (Gueraud et al., 2010). This 
initiates a propagation reaction via lipid radical oxidation, which in turn reacts 
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with a fresh lipid, invariably creating another lipid radical and the unstable lipid 
hydroperoxyde, inevitably continuing the chain reaction (Gardner, 1989; Gueraud 
et al., 2010). Termination of the reaction only occurs when the creation of non-
radical and non-propagating species transpires (Gueraud et al., 2010).  
LP is thought to be associated with various human disease states such as 
Alzheimer’s disease (Pratico and Sung, 2004), atherosclerosis (Minuz et al., 2006) 
and IRI (Adachi et al., 2006). Measuring LP is usually performed analysing the 
stable products of lipid hydroperoxyde, such as malondialdehyde (MDA), 4-
hydroxy-nonenal (4-HNE) or isoprostanes (Powers et al., 2010b). MDA for 
example is commonly assessed via the use of thiobarbituric acid reactive species 
(TBARS) assay kits, however, most of the TBARS found in human samples 
appear not to be related to LP or MDA, therefore use of high performance liquid 
chromatography is recommended as a preferred method (Halliwell and Whiteman, 
2004).  
2.1.4.2 Protein Oxidation 
ROS undergo numerous reactions (electron transfer, hydrogen abstraction, re-
arrangement) with protein peptides during oxidative stress, ultimately disrupting 
the functionality of the protein structure (Hawkins and Davies, 2001). The 
majority of free radical attacks are focused upon the peptide side-chains and the 
protein back-bone, forming a multitude of radicals due to the variability of 
potential sites upon both of these protein fragments (Hawkins and Davies, 2001). 
The predominant product of protein oxidation are carbon-centred radicals, which 
are well known precursors to PCs (Sibrian-Vazquez et al., 2010). The most 
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frequently used and reliable technique for assessing protein oxidation is via the 
reaction between 2,4-dinitrophenylhydrazine and PC for spectophotometry 
analysis, based on methods by Levine et al. (1994). Indeed, PC quantification is 
particularly pertinent within this thesis as protein oxidation stimulates the 
activation of HSPs and the heat shock response (Noble et al., 2008) (detailed 
further in section 2.3.2.1).   
2.1.4.3 DNA Damage  
DNA damage is considered the most serious of ROS induced alterations as DNA 
is merely copied, provoking mutations into the base sequence of replicated  
nucleic acids (Poulsen, 2005). The majority of DNA damage is caused by ROS 
and it is estimated that 2 x 10
4
 damaging events occur in every human cell every 
day (Barzilai and Yamamoto, 2004). This ROS mediated damage occurs due to 
oxidising of nucleic bases, splitting DNA cross-links and breaking single/double 
DNA strands (Barnes and Lindahl, 2004). Fortunately, the body operates effective 
systems in repairing DNA modifications through base-excision and nucleotide-
excision repair pathways (Brierley and Martin, 2013). DNA alteration is 
considered to be a pathophysiological factor in the development of cancer 
(Poulsen, 2005) and is often detected via oxidised by-products utilising high 
performance liquid chromatography and mass spectrometry techniques (Weimann 
et al., 2001). 
Increased protein damage is associated with delayed wound healing and is 
speculated, in part, to be produced via oxidative stress (Moseley et al., 2004). 
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Therefore, alleviation of tourniquet mediated oxidative stress following TKR 
surgery may help to reduce wound healing durations.  
2.2 Peri-Operative 
The induction of oxidative stress through increased radical production and the 
concomitant failure in antioxidant defences invariably leads to cellular structural 
degradation. The subsequent description will outline the molecular events that 
occur during tourniquet inflation in the peri-operative phase of TKR surgery, 
eventually leading to the developing stages of oxidative stress and associated 
cellular damage.   
2.2.1 Ischemia 
Tissue distal to the tourniquet becomes ischemic and hypoxic (Clarke et al., 
2001), consequentially disturbing aerobic metabolism, invariably placing greater 
demands upon anaerobic sources (Grace, 1994). Oxygen is an essential fuel 
source for cellular metabolism, replenishing ATP concentrations via the electron 
transport chain (ETC) in the mitochondria (Tortora and Grabowski, 1996). 
However, during ischemia, glycolysis becomes the main source of ATP re-
synthesis, but this process in turn, also increases the ratio of nicotinamide adenine 
dinucleotide phosphate (NADP)/reduced NADP (NADPH) in addition to lowering 
the pH, consequentially slowing the glycolytic process via inhibition of GAPDH 
(Jennings and Reimer, 1991). As ATP re-synthesis slows beyond cellular usage, 
adenosine diphosphate (ADP) concentrations rise, allowing two of these 
molecules to be converted into ATP and adenosine monophosphate (AMP), where 
the latter undergoes eventual degradation to hypoxanthine (HXA) if O2 is not 
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restored (Jennings and Reimer, 1991). Under normal homeostatic situations, 
metabolites would be removed by the circulation, but during blood flow occlusion 
concentrations are allowed to accumulate (Grace, 1994). In addition, the hypoxic 
conditions also up-regulate the enzyme xanthine oxidoreductase (XOR) which 
catalyses HXA into xanthine (XA) and XA into uric acid in the presence of 
oxygen (Hassoun et al., 1998). Limb ischemia can last for up to (mean ± SD) 145 
± 25 min during TKR surgery (Horlocker et al., 2006). This prolonged blood 
occlusion can lead to significant cell necrosis and tissue damage, therefore 
restoration of blood flow is paramount (Lefer and Lefer, 1996). 
Paradoxically, ischemia itself appears not to induce as severe damage in 
comparison to the re-introduction of oxygen after a bout of blood flow-occlusion 
(Parks and Granger, 1986a). This illogical phenomenon and subsequent tissue 
damage has been named IRI and has a very complex pathophysiology (Lefer and 
Lefer, 1996).  
2.2.2 Reperfusion 
An appropriate beginning is with the many cellular regions in which oxidative 
stress can be derived. Once surgery is completed and the tourniquet has been 
deflated, the re-occurrence of blood flow to the hypoxic tissue leads to a rapid 
induction of free radicals which has been cited as a major factor of oxidative 
stress leading to IRI (Grace, 1994). Outlined below are the major sources of free 
radicals which lead to the disruption of the redox balance and consequential 
cellular damage, and eventual delay in wound healing following IRI.     
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2.2.2.1 Mitochondrial Derived Free Radicals 
The ischemic environment is hypothesised to disrupt the mitochondrial ETC; this 
disruption leads to inefficient electron transfer and increased ROS production 
upon reperfusion (Murphy and Steenbergen, 2008). Indeed, inhibition of the ETC 
at complex I during ischemia has been demonstrated to diminish IRI in cardiac 
tissue (Lesnefsky et al., 2004). Three extensively studied factors regulate 
mitochondrial ROS production; mitochondrial membrane potential (MMP), Ca
2+
 
concentrations and NO availability (Zhang and Gutterman, 2007). High MMP 
promotes ROS generation via slowing of the ETC and prolonging the 
ubisemiquinone radical immediate at complex III, known to be a considerable site 
of O2
•-
 production (Zhang and Gutterman, 2007).  
Mitochondria play a key role in Ca
2+ 
homeostasis, providing a transient location 
for Ca
2+
 storage, elevating inter-mitochondrial membrane Ca
2+
 concentrations 
(Bernardi, 1999). Ca
2+
 stimulates ROS generation through activation of the 
tricarboxylic acid cycle, thus enhancing the work rate of the mitochondrion and 
augmenting ROS output (Brookes et al., 2004). Ca
2+
 can also initiate NO 
production, leading to inhibition of complex IV, again enhancing the radical 
stimulating intermediate, ubisemiquinone (Cleeter et al., 1994). The ineffective 
electron transfer stimulates the production of the free radical O2
•-
, damaging 
mitochondrial proteins and further exacerbating the disruption upon the ETC 
(Baines, 2009). The polarity of O2
•-
 makes it difficult for diffusion across the 
mitochondria membrane, with the mitochondrial permeability transition pore 
(mPTP) serving as the only conduit for its transport (Han et al., 2003). The most 
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important mechanism for intermembrane transport of O2
•-
 is via its conversion 
into the uncharged H2O2, which can easily diffuse across membranes into the 
cytosol (Zhang and Gutterman, 2007).  
The role of mitochondrial derived ROS is well established in the pathophysiology 
of sustained ischemia and reperfusion (Lesnefsky et al., 2004; Baines, 2009), thus 
would contribute to macromolecule damage and redox disturbances observed in 
tourniquet application (Koca et al., 2011).  
2.2.2.2 Xanthine Oxireductase 
The accumulation of HXA during the ischemic bout allows for its conversion via 
XOR once molecular oxygen is restored and has been implemented as a key 
contributor of ROS production during ischemia-reperfusion (Granger et al., 1986). 
XOR has two inter-convertible forms; XO and xanthine dehydrogenase both of 
which are capable of converting HXA and XA, only differing due to the former 
able to catalyse exclusively via reducing oxygen (Figure 2.3) (Berry and Hare, 
2004).  
 
Figure 2.3: Diagram representing the degradation of hypoxanthine following the 
re-introduction of oxygen. Abbreviations: O2 – oxygen molecule; H2O2 – 
hydrogen peroxide. Adapted from Berry & Hare (2004).  
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The conversion of XOR to XO is initiated in hypoxic conditions (George and 
Struthers, 2009) and is the main component for XOR derived ROS via generation 
of  by-products H2O2 and O2
•-
 (Berry and Hare, 2004). In mammals, the highest 
proportion of XOR is observed in the small intestine and the liver (Parks and 
Granger, 1986b), although in humans the majority of XOR is an inactive state 
(Berry and Hare, 2004). It has also been reported that it exists solely in the 
cystoplasm of cells (Ichikawa et al., 1992), although this is under some debate 
(Frederiks and Vreeling-Sindelarova, 2002).  
Several lines of evidence have implicated XO in the pathophysiology of IRI. 
Anoxic aortic endothelial cells demonstrated large bursts of ROS after ischemia-
reperfusion, and were linked to the activity of XO (Zweier et al., 1994). Indeed, 
XO derived by-products have also been linked to cardiac dysfunction in rat hearts 
after ischemia-reperfusion, which was reduced following treatment with the ROS 
scavenger allopurinol (Brown et al., 1988). Furthermore, implementation of XO 
inhibitors abolished free radical creation in rat brain during a bout of ischemia-
reperfusion (Phillis et al., 1994). These findings were also supported by another 
XO inhibitor (BOF-4272) which abolished lipid membrane peroxidisation in 
hepatocytes in an in vitro model (Kakita et al., 2002). However, there is 
controversy to whether XO actually contributes to the ischemia reperfusion 
radical production. Lindsay et al. (1990) performed 5 hrs of ischemia upon ex-vivo 
canine gracilis muscle and measured small increases in IRI precursors HXA and 
XA, in addition to a minor increase in XO activity between 5 and 15 min after 
initial reperfusion. Nevertheless, there were no apparent rises in uric acid which 
would be the expected by-product from this enzymatic reaction. Surprisingly, this 
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article did fail to assess any markers of tissue damage which may have provided a 
clear link to whether the low conversion of HXA/XA to uric acid corresponded to 
similar levels of tissue injury.  
As tourniquet inflation has been attributed to inducing IRI (Estebe et al., 2011) 
and XO is considered to contribute to IRI (Carden and Granger, 2000), it therefore 
could be speculated that XO participates in tourniquet mediated ROS generation.    
2.2.2.3 Leukocytes  
The significance of XO derived ROS in IRI has been disputed with some authors 
favouring the role of leukocytes as the major source of ischemia-reperfusion 
mediated oxidative stress. Under normal circumstances, synthesis of NO is 
produced by endothelial nitric oxide synthase (eNOS) utilising molecular oxygen 
and L-arginine in the presence of the essential co-factor 5,6,7,8-
tetrahydrobiopterin (BH4) (Perkins et al., 2012). However, BH4 is easily oxidised 
to dihydrobiopterin if oxidant radicals overwhelm key intracellular antioxidant 
defence mechanisms such as glutathione or vitamin E (Crabtree et al., 2008). The 
reduction in BH4 concentrations cause eNOS to switch from NO production to the 
O2
•-
 radical, thus furthering oxidation of BH4 (Schmidt and Alp, 2007; Crabtree et 
al., 2008). A reduction in NO release has been cited frequently in relation to IRI 
(Lefer and Lefer, 1996; Carden and Granger, 2000; Khanna et al., 2005; Perkins 
et al., 2012), and appears to be related to the abrupt release of O2
•-
 upon 
reperfusion inhibiting NO synthesis (Ma et al., 1993). Moreover, as mentioned in 
section 2.1.2, the increased availability of O2
•-
 provides NO the ability to react and 
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produce the potent radical ONOO
-
 accumulating to the exacerbation of oxidative 
stress (Crabtree et al., 2008).  
Leukocytes are recruited to the ischemic site via cytokines, chemokines and 
cellular selectins expressed on the endothelial cells (ECs) (Jaeschke, 2003). 
Leukocytes free-flowing in the microcirculation pass the ECs and respond to 
inflammation mediated selectins, progressively slowing in a process known as 
leukocyte rolling (Kansas, 1996). P-selectin expressed on ECs has been 
implicated as the dominate receptor for leukocyte rolling (Carden and Granger, 
2000), which is found within intracellular Weibel-Palade bodies and is rapidly 
exteriorised to the cell surface membrane within minutes of agonist (histamine, 
thrombin, H2O2) stimulation (Kansas, 1996; Lefer and Lefer, 1996). P-selectin 
glycoprotein ligand-1 on the surface of leukocytes is the principle ligand for P-
selectin and results in intergrin activation which links leukocyte rolling with fixed 
cellular adhesion (Langer and Chavakis, 2009). ß2 intergrin (CD11b/CD18) 
present in leukocytes have also been implemented as the principle molecule for 
firm adhesion of leukocytes to the EC membrane via the membrane’s counter-
receptor, intracellular adhesion molecule-1 (ICAM-1) (Lefer and Lefer, 1996). 
Once bound, the activated leukocytes release proteases which are capable of EC 
membrane degradation, in addition to release of H2O2 and O2
•- 
inducing oxidative 
stress (Carden and Granger, 2000). Furthermore, bound leukocytes infiltrate the 
tissue through the endothelial barrier resulting in greater endothelial damage and 
edema formation (Nedrebo et al., 2003).  
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Strong evidence implicates the role of leukocytes in IRI. Investigation into mice 
deficient in CD11/CD18, P-selectin or ICAM-1 demonstrated complete protection 
from mesenteric artery EC injury after a 45 min bout of ischemia-reperfusion 
(Banda et al., 1997). These results were corroborated by Connolly et al. (1996) 
who found a 3.7 fold reduction in infarct size from 45 min ischemia  followed by 
22 hrs reperfusion on the cerebral artery in ICAM-1
(-/-)
 mice compared with 
ICAM-1
(+/+)
 control mice. Furthermore, canines administered with a CD18 
intergrin neutralising antibody demonstrated a diminution of myocardial infract 
size in comparison to control after ischemia-reperfusion (Duilio et al., 2001). As 
previously mentioned, NO has been intrinsically linked with IRI. Indeed, 
inhibition of endogenous NO synthesis increased vascular leukocyte rolling in 
humans (Hossain et al., 2012). In addition, administration of NO (via NO donor 
S-nitroso-N-acteylpenicilleamine (SNAP)) has also shown to be effective in 
diminishing leukocyte rolling and adhesion (Dal Secco et al., 2006). However, the 
administration of SNAP has been shown to aggravate IRI through greater free 
radical generation (Zhang et al., 2003) demonstrating the difficulty of exogenous 
NO donor administration in attempting to prevent IRI.       
These results clearly depict an integral role for leukocyte, mitochondrion and 
XOR in contributing to greater free radical production (Figure 2.4) and ensuing 
oxidative stress experienced during IRI. Hence, the oxidants produced through 
XOR during initial re-oxygenation suppress NO release and augmented O2
•-
 
production initiating leukocyte rolling and increased oxidant production 
respectively, thus inevitably disrupting the redox balance. As redox homeostasis is 
paramount in avoiding cellular injury (Zweier and Talukder, 2006), diminishing 
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the associated redox balance disturbances during tourniquet inflation/deflation 
would minimise the chance of wound complications associated with oxidative 
stress (Soneja et al., 2005; Estebe et al., 2011).     
 
Figure 2.4: Illustration of potential reactive oxygen species (ROS) production 
during ischemia-reperfusion. Abbreviations: O2
•- 
- superoxide anion; NO – nitric 
oxide; ONOO
-
 - peroxynitrite. Adapted from Powers et al. (2010).        
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(muscle, liver) are more commonly measured in rodent models. Puntel et al. 
(2013) noted a reduction in GSH/GSSG ratio following 3 hrs of ischemia and 2 
hrs of reperfusion in rat gastrocnemius muscle. A reduction in GSH 
concentrations alone have also been reported post 4 hrs ischemia and 2 hrs 
reperfusion in rat gastrocnemius muscle (Avci et al., 2012). During aorta-biformal 
bypass surgery on elective patients, GSH concentrations were noted to 
significantly decrease 24 hrs after initial reperfusion from ischemia (median ± 
range; 113 ± 21) in comparison to preoperative levels (Westman et al., 2006). 
Surprisingly, the ratio of GSH/TGH was not significantly different from 
preoperative levels, as augmented oxidative stress would be expected to create 
greater concentrations of GSSG, diminishing the GSH/TGH ratio (Halliwell and 
Gutteridge, 2007). Although this may be due to extracellular exportation of GSSG 
(Ballatori et al., 2009).  
The literature collectively presents the disruption caused to the localised tissue 
concentrations of GSH via ischemia-reperfusion. However, controversy exists in 
relations to glutathione disruption in blood sampling. A significant increase in 
GSSG was noted in systemic blood taken from the antecubital region at 3 and 10 
min in reperfusion after TKR surgery (Garcia-de-la-Asuncion et al., 2012). 
Interestingly, whole blood samples obtained from the operated knee also 
displayed an increase in GSSG but at much greater concentrations. This disparity 
between observed GSSG/GSH at localised and systemic sites has also been noted 
by Karg et al. (1997). The authors demonstrated a significant increase in the 
whole blood GSSG/GSH ratio at 5 min reperfusion in the operated leg when 
compared to samples obtained from the arm. Finally, whole blood sampled at the 
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site of ischemia in knee surgery patients (femoral vein) acquiesced a significant 
change in whole blood GSH and GSSG in comparison to sampling from a 
systemic source (antecubital vein) (Mathru et al., 1996). Research from Garcia-de-
la-Asuncion et al. (2012), Karg et al. (1997) and Mathru et al. (1996) indicate that 
the site of blood sampling can affect the yielded concentrations of glutathione 
from a bout of ischemia-reperfusion. Therefore, GSH/GSSG concentrations will 
provide a useful insight into redox changes induced via the hypoxic intervention 
following TKR specific tourniquet application.           
2.2.4 Ischemia-Reperfusion and Macromolecule Damage 
The large oxidative burst initiated by reperfusion has a detrimental effect upon 
localised tissue damage once the antioxidant defence is overwhelmed. Increased 
levels of lipid peroxidation (4-HNE) were observed after 3 hrs of ischemia and 
only 5 min of reperfusion in murine hind limb (Adachi et al., 2006). Hori et al. 
(2013) found increased concentrations of MDA at 24 hrs reperfusion following 
1.5 hrs of ischemia in both rat gastrocnemius and anterior tibialis. Furthermore, 
increased levels of TBARS were observed at 10 min reperfusion in a clinical 
population undergoing lower-leg extremity surgery (mean ± SD; 78.7 ± 13.3 min 
of tourniquet inflation) when compared with baseline figures (Van et al., 2008). 
However, as previously mentioned, TBARS are not specifically generated via LP 
(Halliwell and Whiteman, 2004), therefore the results should be interpreted with 
caution. Interestingly, ischemia alone induces lipid peroxidation, and is 
exacerbated further upon reperfusion (Paradies et al., 1999). Greater lipid 
peroxidation was also noted in hepatic (Lee et al., 2000) and brain tissue 
(Sakamoto et al., 1991) post ischemia-reperfusion.  
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The deteriorated integrity of the cellular membrane from the reperfusion 
associated oxidative attack leads to intracellular protein degradation (Halliwell 
and Chirico, 1993). Similar to lipid peroxidation, the literature displays decisive 
evidence for the role of ischemia-reperfusion in increasing protein oxidation. PC 
concentrations were elevated in rat gastrocnemius muscle following 4 hrs of 
ischemia and 2 hrs reperfusion in comparison to a SHAM condition (Avci et al., 
2012). These results were collaborated by Ozyurt et al. (2006) who noted a rise of 
rat gastrocnemius PC concentration in the ischemia-reperfusion group when 
analysed against a control. Conversely, Ozkan et al. (2012) found no significant 
difference in PC concentrations in rat tibialis anterior between control and 
ischemia-reperfusion condition subsequent to 3 hrs ischemia and 15 min 
reperfusion. However, the ischemic-reperfusion condition did display a trend for 
increased PC concentrations in comparison to control and may be due to a fairly 
low participant number (n = 6 control, n = 10 ischemia-reperfusion). 
The evidence outlined above demonstrates ischemia-reperfusion as a key player in 
macromolecule damage and that varied durations of ischemia (1.5 – 3 hrs) all 
provoke disruption in cellular structures. Thus, assessment of macromolecule 
damage would provide a useful marker in measuring consequent effects of 
improvements in redox disruptions following the hypoxic intervention.   
2.2.4.1 Apoptotic Cell Death 
Excessive macromolecule damage via augmented free radical production 
commences activation of the intrinsic apoptosis pathway, through the initiation of 
energy-dependant cascades (Elmore, 2007). Oxidative stress mediated DNA 
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damage stimulates the tumor suppressor protein, p53, to initiate either DNA repair 
or, stimulate the apoptotic cascade via trans-activation of the large Bcl-2 family 
(Elmore, 2007; Kroemer et al., 2007). The Bcl-2 protein group consist of both 
pro- (Bax, Bak, Bid) and anti-apoptotic (Bcl-2, Bcl-XL, Bcl-x) members and are 
maintained in a hierarchical model (Liu et al., 2010). P53’s induction of Bax 
motivates the pro-apoptotic protein to bind to the mitochondrial outer membrane 
inducing mPTP, either alone or with other Bcl-2 pro-apoptotic members, thus 
allowing translocation of very large molecules (Kuwana et al., 2002). The large 
pore alters the permeability of the mitochondrial membrane, disrupting ATP 
synthesis and inducing an influx of Ca
2+
, releasing cytochrome c subsequently 
promoting the formation of the caspase-activating Apaf-1 apoptosome (Crompton, 
1999; Hill et al., 2004). Interestingly, Ca
2+
 influx may not be directly accountable 
for mitochondrial dysfunction as inhibition of calpain (downstream Bid cleaver) 
offers myocardial protection from IRI (Chen et al., 2002). The apoptosome 
triggers caspase-9 to become active, initiating caspase 3 leading to eventual 
cellular organelle proteolysis, DNA fragmentation and decisive phagocytosis of 
the apoptotic bodies (Elmore, 2007).  
There is an array of evidence to link ischemia-reperfusion with cellular apoptosis. 
Ex-vivo rat hearts participated in 15 min ischemia and 60 min reperfusion, 
demonstrating large levels of apoptotic cell death in comparison to control and 
that blockade of oxidative stress upon reperfusion diminished programmed cell 
death (Maulik et al., 1998). These results have also been collaborated by Galang 
et al. (2000). Galang and colleagues (2000) showed a dramatic increase in 
apoptotic ex-vivo myocardiocytes after 30 min ischemia and 120 min reperfusion 
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in comparison to control and that the addition of SOD diminished this negative 
consequence. However, apoptosis is an energy-dependant process and prolonged 
exposures to ischemia can lead to vast ATP depletion (Kim et al., 2003; Elmore, 
2007). If enough of the cells’ mitochondria are damaged, necrotic death will ensue 
rather than the favourable apoptosis (Yang et al., 2010). Nevertheless, there is no 
precise feature for either apoptosis or necrosis as both share similar mechanistic 
pathways, invariably creating difficulty when distinguishing between the two 
(Jaeschke and Lemasters, 2003).  
Apoptosis is cited to play a role in the pathophysiology of skeletal muscle cell loss 
(Dirks and Leeuwenburgh, 2002) and occurs during ischemia reperfusion 
following cellular lipid peroxidation (Maulik et al., 1998). Therefore, an 
intervention which could attenuate apoptosis during tourniquet mediated IRI may 
enhance recovery times post TKR surgery.  
2.2.4.2 Necrotic Cell Death 
Necrosis is characterised by cytoplasmic bulging, plasma membrane rupture and 
organelle damage, resulting in inflammation due to release of cellular components 
(Festjens et al., 2006). Tumor necrosis factor-α (TNF-α) produced primarily from 
activated macrophages can induce either cell survival or cell death depending on 
the cellular environment via ligand-binding with death receptors, TNF-R1 and 
TNF-R2 (Chen and Goeddel, 2002; Festjens et al., 2006). Although necrosis and 
apoptosis have very different outcomes, both can be initiated by TNF-α, 
depending on caspase inhibition (Vanden Berghe et al., 2004). TNF-α cascade 
signalling induction of Fas-associated death domain mediates apoptosis (Chen et 
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al., 2002), while receptor-interacting protein triggers necrotic cell death (Hsu et 
al., 1996).  
TNF has been demonstrated to provoke skeletal muscle injury during ischemia-
reperfusion, since antibody blockade of TNF resulted in a reduction in skeletal 
muscle injury (Gaines et al., 1999). This result is in collaboration with Seekamp et 
al. (1993) who noted a reduction in skeletal and lung injury through TNF 
obstruction. However, TNF blockade by Sternbergh et al. (1994) did not present a 
reduction in skeletal muscle endothelial injury, suggesting that TNF may not play 
a primary role in IRI injury. Interestingly, post TKR surgery, only moderate rises 
in cytokine concentration (TNF, interlukin-1) have been observed after 2 hrs 
reperfusion (Clementsen and Reikeras, 2008), although this moderate 
accumulation of cytokines is in disagreement with Seekamp et al. (1993). The low 
levels of cytokine observed by Clementsen and Reikeras (2008) in comparison to 
Seekamp and colleagues (1993) may in part be due to the large disparity between 
ischemic durations (78-125 min and 4 hrs respectively).   
Skeletal muscle necrosis via IRI has been cited to affect muscle function through 
decreased muscle twitch and contractual force (Kearns et al., 2001), thus an 
attenuation of this muscle detriment could improve the surgical outcome of TKR 
patients.  
2.2.4.3 Toll-Like Receptors 
Necrotic signalling transduction is not just limited to the death receptor pathway, 
toll like receptors (TLRs) have also been implicated in invoking IRI. TLRs are a 
family of leucine rich transmembranal proteins involved in regulating innate and 
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adaptive immune response to pathogenic invaders (Takeda et al., 2003). TLRs are 
present on immune cells, such as macrophages (Hadley et al., 2007) and non-
immune cells including skeletal muscle (Frost et al., 2006). TLRs have been 
implicated to participate in the pathophysiology of IRI (Arumugam et al., 2009; 
Khandoga et al., 2009) with TLR-2 (Favre et al., 2007) and TLR-4 (Kaczorowski 
et al., 2007) implicated as major participators. HSPs and high mobility group box-
1 proteins among others, are considered ligands for TLR-2 and TLR-4, which are 
secreted into the surrounding environment from stimulated leukocytes (Park et al., 
2004; Arumugam et al., 2009). The stimulation of TLRs induce numerous 
intracellular signalling cascades via mitogen activated protein kinase (MAPKs) 
and IκB kinase, which are very similar to the interlukin-1 pathway resulting in the 
stimulation of pro-inflammatory transcription factors such as nuclear factor-κB 
(NF-κB) and activator protein 1 (AP-1) (Takeda et al., 2003; Arumugam et al., 
2009). The consequential activation of NF-κB and AP1 induces a plethora of 
functions including a greater expression of cytokines, adhesion molecules and 
chemokines (Batra et al., 2011). 
Research into TLR-2
(-/-)
 knockout mice has been shown to abolish endothelial 
dysfunction when compared with wild type mice in cardiac tissue after 30 min 
ischemia and 1 hr reperfusion (Favre et al., 2007). The reduction in endothelial 
dysfunction was attributed to a reduction in ROS production and leukocyte 
infiltration. In fact, this explanation was confirmed by Khandoga et al. (2009). 
The authors utilised TLR-2
(-/-)
 knockout mice with the addition of mice with 
mutant TLR-4 receptors and demonstrated that after ischemia-reperfusion a 
reduction in neutrophil endothelial migration was noticed in comparison to mutant 
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TLR-4 receptor mice, in addition both TLR-2
(-/-)
 knockout and TLR-4 mutant 
mice displayed attenuated vascular leakage. Indeed, the use of circulatory TLR-2 
antibody inhibitors reduced infarct size and diminished functional capacity in 
murine hearts post ischemia-reperfusion (Arslan et al., 2010). This suggests that 
TLR-2 plays an important role with trans-endothelial migration of leukocytes in 
IRI.  
Similar results in IRI were also observed in TLR-4
(-/-)
 knockout mice (Oyama et 
al., 2004) and blockade of TLR-4 via eritoran (Shimamoto et al., 2006). Although 
both TLR-4 and TLR-2 appear to be in part responsible for the innate 
inflammatory response during IRI, the latter is illustrated to have a greater role in 
neutrophil migration (Khandoga et al., 2009).  
The culmination of the factors above, in addition to the tissue hypoxia, could 
negatively affect wound healing following prolonged tourniquet use (Estebe et al., 
2011). Therefore, interventions are required to attenuate the duration of wound 
healing associated with tourniquet use in TKR surgery.     
2.3 Ischemic Pre-Conditioning 
To avoid the deleterious effects of IRI multiple strategies have been proposed. 
Numerous studies have administered supplements to mitigate the damage 
sustained via IRI (Nedrebo et al., 2003; Ozyurt et al., 2006; Avci et al., 2012; Hori 
et al., 2013). However, pharmacological interventions must be timed perfectly, as 
well as administered in correct doses with regards to intravenous administration, 
to ensure the drug has reached the tissue prior to the ischemic insult and in a 
significant quantity (Wang et al., 2002). In addition, rigorous testing of novel 
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pharmaceuticals is required to avoid fatal interactions with anaesthesia (Weldon-
Bellville, 1972). Furthermore, many of the trials used for supplementation 
administration are performed on healthy individuals and the effect of 
pharmaceuticals upon patients who are morbidly obese (often associated with 
diabetes type II, cardiovascular disease, sleep apnoea) is not well understood 
(Wang et al., 2002; Samson et al., 2010). Interestingly, morbidly obese is 
considered an independent cause of knee osteoarthritis (Samson et al., 2010) and 
morbidly obese individuals contribute to around 28% of total primary TKR 
patients (Dehn, 2007), thus a non-pharmaceutical intervention would be 
beneficial.  
In contrast to supplementation, a landmark study conducted by Murry et al. (1986) 
involved a group of dogs receiving 4 cycles of 5 min coronary occlusion and 5 
min reperfusion, prior to 40 min of solid coronary ischemia and a 4 day 
reperfusion period. Surprisingly, the dogs who received the ischemic/reperfusion 
cycles displayed a reduction in infract size in comparison to a control group only 
receiving 40 min occlusion. This technique has been aptly termed ischemic 
preconditioning (IPC) and since this discovery by Murry and colleagues (1986) 
many researchers have pursued this phenomenon in various tissues other than 
cardiac muscle, including hepatic (Yoshizumi et al., 1998), skeletal muscle (Saita 
et al., 2002), brain (Dawson and Dawson, 2000) and renal tissues (Toosy et al., 
1999). Thus, to establish the extent of which the non-invasive hypoxic 
preconditioning can attenuate tourniquet mediated oxidative stress, a comparison 
to a previously used non-invasive technique is required.                         
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The mechanism by which IPC protects tissue against IRI is not fully understood 
(Yang et al., 2010), however, it has been established that the protective effects 
appear in a biphasic pattern (Das and Das, 2008). The early phase is proposed to 
last between 2-3 hrs (Yang et al., 2010), while a delayed phase appears 24 hrs 
after the IPC protocol and can last up to 3 days (Hausenloy and Yellon, 2010) 
(Figure 2.5).  
 
Figure 2.5: Schematic depicting a list of potential mediators and the proposed 
time frame for the protection offered by ischemic preconditioning. Abbreviations: 
PKC – protein kinase C; ROS – reactive oxygen species; HSP70 – heat shock 
protein 70; HSP32 – heat shock protein 32; COX-2 - Cyclo-oxygenase 2; RISKs – 
reperfusion injury salvage kinases. 
  
2.3.1 Early Phase 
Early phase IPC protection has been linked to the activation of G-coupled 
adenosine receptors via the release of endogenous adenosine during the brief 
ischemia (Liu et al., 1991). Stimulated adenosine receptors main target during 
Time Succeeding Ischemic Preconditioning (hrs) 
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early IPC is the family of 12 serine/threonine kinases known as protein kinase C 
(PKC) (Cohen et al., 2000). It has been hypothesised that stimulation of PKC 
activates 5’-nucleotidase, generating larger concentrations of adenosine via 
degradation of AMP, which is of abundance during ischemia (Kitakaze et al., 
1995). Additionally, PKC is thought to be initiated directly via ROS signalling as 
intravenous administration of free radical scavengers removes the protection 
granted from IPC (Baines et al., 1997), while cellular models have demonstrated 
that the addition of oxidants promotes preconditioning (Vanden Hoek et al., 
1998).      
Mitchell et al. (1995) demonstrated that PKC activator, 1,2-diacylglycerol (DAG) 
produced similar cardio-protective effects to IPC in ex-vivo rat hearts. Moreover, 
blockade of PKC abolished the protective effect offered from IPC. The negated 
effects of IPC were also noted by Ytrehus et al. (1994) following PKC blockade 
in rabbit hearts. However, the specific PKC isoenzyme that contributes to IPC is 
still in debate. PKC-δ(-/-) knockout mice displayed augmented ischemic tissue 
damage following IPC (Mayr et al., 2004). Conversely, Bright et al. (2004) noted 
that inhibition of PKC-δ reduced cerebral IRI in rats, indicating the equivocal 
nature of PKC-δ in inducing IPC. However, it appears that PKC-ε is essential for 
IPC protection (Ping et al., 2002), and that knockout mice deficient in PKC-ε 
displayed inhibited protection afforded from IPC (Saurin et al., 2002). 
Consequently, PKC-δ may not be essential in IPC unlike the isoform PKC-ε.    
IPC is proposed to act on the mPTP, offering protection through maintaining 
inhibition of pore opening (Das and Das, 2008). As previously mentioned, (in 
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section 2.2.4.1) opening of the mPTP has catastrophic effects upon the 
mitochondria, with eventual apoptosis ensuing. Mitochondrial potassium ATP 
(mKATP) channel activation has been linked to inhibiting mPTP opening, although 
the mechanisms involved are unclear (Hausenloy et al., 2002). The activation of 
PKC-ε via adenosine allows the stimulated serine/threonine kinase to open the 
mKATP channel (Hu et al., 1999). Influx of K
+
 into the mitochondria maintains 
Ca
2+
 concentrations via reducing the electrochemical gradient for Ca
2+
 movement 
into the mitochondria (Holmuhamedov et al., 1999) thus restraining Ca
2+
 
mediated mPTP opening and subsequent apoptosis. It has also been speculated 
that PKC-ε may regulate the apoptosis through coimmunoprecipitation to 
components of the mPTP (voltage dependant anion-selective channel, adenine 
nucleotide translocase) inhibiting mPTP opening (Yonekawa and Akita, 2008).  
Therefore, any immediate reduction in oxidative stress markers from IPC to a 
subsequent bout TKR specific tourniquet application would involve the 
mechanisms outlined above.      
 2.3.2 Delayed Phase 
After the initial 2 hr window of protection offered by IPC, the delayed phase takes 
effect 24 hrs post preconditioning and has been attributed to altered gene 
expression and de novo synthesis of proteins (Carden and Granger, 2000). 
Mediators of delayed protection are generally protein kinases which are activated 
during the IPC stimulus resulting in activation of transcription factors (Hausenloy 
and Yellon, 2010).  
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The established mediator of early protection, PKC, has also been implicated to 
produce delayed protection (Qiu et al., 1998). Qiu et al. (1998) demonstrated 
inhibition of PKC after the ischemic stimulus did not abolish the protection 
offered by IPC suggesting crucial activation of PKC occurs during the ischemic 
bout. Qiu and colleagues (1998) also established that general activation of PKC 
without ischemia mimicked the effects of delayed IPC. MAPKs have also been 
recognised as delayed protection mediators via upstream stimulation from PKC 
(Xuan et al., 2005). Indeed, research by Fryer et al. (2001) noted the integral role 
of extracellular signal regulated kinase (ERK) and p38 MAPK in delayed 
cardioprotection. The stimulation of mediators initiates activation of a variety of 
cell stress signalling transcription factors associated with delayed IPC such as 
hypoxia induced factor -1α  (Xi et al., 2004), NF-κB (Xuan et al., 1999) and AP-1 
(Li et al., 2000). Although, it has been suggested that transcription factors can be 
recruited differentially and still induce the requisite delayed protection 
(Hausenloy and Yellon, 2010). Cell stress transcription factors can be induced via 
a differing stress (e.g. hyperthermia) but still yield protection from IRI, 
demonstrating a cross-tolerance effect (Horowitz et al., 2004). Therefore, hypoxic 
preconditioning could yield delayed protection from ischemia via stressor cross-
tolerance. 
2.3.2.1 Antioxidant enzymes  
Transcriptional mediators of delayed IPC are proposed to up-regulate antioxidant 
enzymes (Hausenloy and Yellon, 2010), including, peroxisomal catalase, 
glutathione peroxidase and MnSOD (Das et al., 1993). MnSOD is a key 
mitochondrial protein which is synthesised in the cytoplasm and imported 
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posttranslationally into the mitochondria, where it functions to catalyse the 
dismutation of O2
•- 
into H2O2 and molecular oxygen (Jin et al., 2005). Dramatic 
increases in MnSOD have been noted 24 hrs following a bout of IPC in canine 
hearts (Hoshida et al., 1993). Indeed, Zhou et al. (1996) also demonstrated greater 
MnSOD induction and activity 24 hrs following IPC in rat myocytes in 
comparison to control. However, not all research has verified increases in 
MnSOD activity succeeding IPC. Tang et al. (1997) showed that delayed IPC did 
not increase MnSOD activity in porcine hearts. Nevertheless, the discrepancy in 
results observed by the various research groups may be attributable to specie or 
IPC protocol differences. Regardless of these variances, it is likely that an 
increase in MnSOD following IPC would partially augment protection from future 
ischemic insults.             
2.3.2.2 Heat shock protein 72 
Marber and colleagues (1993) were the first to illustrate an increase in HSP72 
following IPC (4 x 5 min ischemia interrupted with 10 min reperfusion) 24 hrs 
earlier in cardiac tissue, with the rise in HSP72 associated with the mechanisms 
involved in delayed preconditioning. HSPs are a family of highly conserved 
cytoprotective proteins ubiquitously found in cells, which function as molecular 
chaperones facilitating folding and transportation of newly synthesised and 
denatured proteins (Morton et al., 2009). In addition, HSPs play a versatile role in 
cellular survival via interaction with molecules associated with the apoptotic 
cascade (Kalmar and Greensmith, 2009). HSPs are defined by their estimated 
molecule weight and tend to be grouped into sub-group families (i.e. HSP70 (70 
kDa)), and are localised throughout various regions of the cell (Morton et al., 
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2009). HSP70 in particular, is highly inducible during stressful situations, 
rescuing damaged proteins and maintaining cellular protein synthetic capacity 
(Noble et al., 2008).      
The coordinated organisation of activated HSP gene expression (Hsp) in response 
to a variety of stressors, including ischemia (Chang et al., 2001), hyperthermia 
(Oishi et al., 2003) and hypoxia (Taylor et al., 2010) is called the heat shock 
response. Under normal physiological conditions, HSP70 is bound to its 
transcription factor, heat shock factor 1 (HSF1), in an inactive monomeric state 
(Abravaya et al., 1992). However, an external stressor induces intracellular 
protein unfolding and denaturation, stimulating the dissociation of the HSP70 and 
HSF1, through HSP70 preferential binding to the damaged protein (Noble et al., 
2008). Unbound, HSF1 undergoes trimerisation with other free HSF1, 
subsequently binding to the heat shock element in the promoters of heat shock 
genes, allowing transcription of additional HSPs (Sarge et al., 1993) (Figure 2.6). 
The integral role of HSP72 during cellular stress and its rapid induction via a 
variety of stressful stimuli make it an excellent marker of redox disturbance 
(Taylor et al., 2012). Indeed, oxidative stress has been cited to up-regulate HSP72 
via signal activation of HSF1 and by directly oxidising cellular proteins (Morton 
et al., 2009). Therefore, a rise in Hsp72 would indicate greater cellular stress 
following the TKR specific tourniquet application.    
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Figure 2.6: Stress induced activation of the heat shock response mechanism. 
Unfolded proteins induce the dissociation of HSP70 from its bound monomeric 
state with HSF1, allowing HSP70 to aid in the refolding of damage proteins. 
Unbound HSF1 trimerises with other free HSF1, subsequently binding the heat 
shock element, initiating transcription. Abbreviations: HSP70 – heat shock protein 
70; HSF1 – heat shock factor 1. Adapted from Nobel, Milne & Melling (2008).    
Since the original observation between delayed IPC and HSPs by Marber et al. 
(1993) subsequent research groups have explored this connection. Okubo et al. 
(2001) injected recombinant adenovirus encoding for HSP70 into in-vivo rabbit 
hearts 4 days prior to 30 mins cardiac ischemia and 3 hrs reperfusion. The authors 
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noted a reduction in infarct size in the HSP70 vector comparison to a saline 
injection alone. This evidence for the role of HSP70 in delayed IPC was also 
observed by hyperthermic preconditioning (Lepore et al., 2000). Lepore and 
colleagues (2000) performed hind limb heating at 42°C for 20 min prior to 2 hrs 
ischemia and 24 hrs reperfusion. The passive heating bestowed a rise in HSP72 
and subsequent protection from the ischemic insult. Interestingly, Tanaka et al. 
(1998) observed increases in HSP70 after just 3 hrs following IPC in rabbit hearts, 
with concentrations remaining detectable by immunohistochemical techniques for 
up to 72 hrs. In contrast to this, Lepore and Morrison (2000) did not observe an 
increase in HSP70 gene expression from 2 x 10 min bouts of ischemia with 15 
min reperfusion interruptions in rat hind limb skeletal muscle. Additionally, the 
authors noted that there was not a significant increase in viable fibres following 2 
hrs of ischemia in comparison to a control group. However, the poor sample 
number (n = 3) and altered preconditioning protocol to previous successful work 
(Marber et al., 1993) may have led to the non-significant result (p = 0.16). 
Interestingly, repeated bouts of endurance exercise can provide a marked rise in 
HSP72 within cardiac tissue (Powers et al., 1998; Demirel et al., 2003) inducing 
protection from IRI (Steel et al., 2004). However, HSP72 is not necessarily 
required to attenuate IRI. Research from Taylor et al. (1999) and Hamilton et al. 
(2001) both demonstrated that exercise bestowed protection from IRI without an 
increase in cardiac HSP72. It is possible that the disparity between cardiac and 
skeletal muscle research may be attributable to varying degrees of HSP72 
dependency in differing tissues. Indeed, Hamilton et al. (2001) postulated that 
protection in cardiac tissue mediated via exercise may be partly due to greater 
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antioxidant capacity. It could therefore be speculated that cardiac tissue relies 
more heavily on antioxidant enzymes in comparison to skeletal muscle which may 
depend more on HSPs, although further research is necessary.            
In summary, HSP72 appears to play a key role in skeletal muscle delayed IPC 
(Marber et al., 1993; Okubo et al., 2001); therefore a deferred increase in Hsp72 
from IPC may indicate the onset of delayed preconditioning.  
2.3.2.3 Heat shock protein 32 
HSP32 (or Heme oxygenase-1) is another member of the cytoprotective family 
associated with delayed IPC (Hausenloy and Yellon, 2010). Free heme is bound in 
hemoproteins during homeostasis, however, during oxidative stress, free heme 
molecules are released from heme pockets within the hemeproteins and in doing 
so produce ROS via Fenton chemistry (Gozzelino et al., 2010). HSP32 is an 
evolutionary conserved enzyme that catabolises the ROS producing free heme 
into biliverdin, carbon monoxide (CO) and iron, (Tenhunen et al., 1968). 
Bilverdin is then available for enzymatic conversation via bilverdin reductase 
(BVR) into the cytoprotective anti-oxidant bilirubin (Clark et al., 2000). 
HSP32 expression is regulated by numerous stress-associated effectors such as 
heme, hyperthermia, and hypoxia (Alam and Cook, 2007). Transcriptional 
activation of HSP32 is controlled by a variety of transcription factors including, 
nuclear factor E2-related factor 2 (NrF2), NF-κB, AP1 and HSF-1 (Kim et al., 
2011). Stressful circumstances have the ability to stimulate multiple transcription 
factor groups simultaneously, with differing group’s regulating slightly different 
aspects in HSP32 stress response (Alam and Cook, 2007). The MAPK cascade 
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appears to be the foremost mediator of HSP32 gene regulation (Figure 2.7), 
involving the three major sub-families, ERK, c-Jun N-terminal kinases (JNKs) 
and p38 kinases (Alam et al., 2004). Indeed, ERK, JNKs and p38 MAPK were all 
attributed to the upregulation of HSP32 following IRI (Zhang et al., 2002).    
 
 
Figure 2.7: Regulation of the HSP32 gene via the major stress-response 
transcription factors. Stimulation of transcription factors occurs through 
MAPK signalling (direct phosphorylation (solid line); signalling cascade 
(dotted line)) or directly by stressful stimuli (grey line). Abbreviations: NrF2 – 
Nuclear factor E2-related factor 2; NF-κB – Nuclear factor-κB; AP1 – 
Activator protein 1; HSF1 – Heat Shock factor 1; MAPK – Mitogen activated 
protein kinases; HSP32 – Heat shock protein 32. Adapted from Alam & Cook 
(2007).   
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Similar to HSP72, the inducible form of HSP32 has also been demonstrated to be 
a marker of oxidant mediated cell damage (Rothfuss et al., 2001). Thus, an 
increase in Hsp32 following tourniquet application, would indicate a rise in 
oxidative stress.       
Myocardial cells undergoing IPC displayed an increase in HSP32 24 hours post 
ischemic stimulus, in addition it to an increase in cell viability in comparison to a 
simulated ischemic group (Jancso et al., 2007). Further evidence for HSP32’s 
induction through IPC was noted by Zeynalov et al. (2009), who performed IPC 
on wild type mice and found a significant increase in protein expression 24 hours 
post stimulus in comparison to a sham control. Furthermore, the anti-oxidant by-
product of HSP32 activity, bilirubin, was noted to be significantly increased in 
IPC rat skeletal muscle in contrast to control (Badhwar et al., 2004). 
2.4 Hypoxic Preconditioning 
HPC has been utilised previously to bestow cellular tolerance as a stratagem to 
avoid deleterious effects from disturbances to the redox balance (Taylor et al., 
2012). Moreover, hypoxic exposure has been described to have similar protective 
effects as IPC in providing tolerance to a subsequent sustained bout of ischemia 
(Beguin et al., 2005). In line with IPC, HPC also offers biphasic protection at 
similar intervals (i.e. within 2 hrs and between 24-72 hrs of stimulus removal) 
(Zhao et al., 2013). Furthermore, both IPC and HPC appear to share similar redox 
pathways in response to hypoxia mediated oxidative stress (Zuo et al., 2013). 
PKC-ε is attributed to an integral role in inducing early IPC, but the kinase has 
additionally been demonstrated to be up-regulated following HPC and that general 
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blockade of all PKC isoforms abolish the protection conferred by the hypoxic 
exposure (Berger et al., 2010). In addition, it has been shown that the increase in 
ROS via HPC initiates ischemic tolerance (Vanden Hoek et al., 1998), perhaps via 
ROS mediated stimulation of PKC. Indeed, PKC-ε has also been shown to up-
regulate HSP32 (Ryter et al., 2006), further elucidating the vital role of PKC-ε in 
HPC. Thus, the HPC undertaken in the present thesis may offer protection to 
tourniquet mediated oxidative stress immediately following the hypoxic exposure.     
The delayed phase of HPC operates in an identical manner to IPC by initiating de 
novo synthesis of proteins (Zhao et al., 2013). HPC has been speculated to 
activate the transcription factor, hypoxia induced factor -1α, which stimulates up-
regulation of target genes including, vascular epidermal growth factor, inducible 
nitric oxide synthase and erythropioetin (Ran et al., 2005). These genes would 
promote greater blood flow and oxygen delivery for subsequent ischemic insults 
(Ran et al., 2005). Moreover, Taylor et al. (2010) noted an increase in monocyte 
HSP72 gene expression following a 75 min period of normobaric hypoxia (14.5% 
O2) in vivo. Indeed, HPC mediated up-regulation of HSP72 has been 
demonstrated to diminish the deleterious effects of IRI in the rat kidney (Yeh et 
al., 2010). Furthermore, HPC has been elicited to increase HSP32 following a 
prolonged hypoxic exposure, attenuating hepatic IRI in rats (Lai et al., 2004).   
The mechanisms outlined above describe the process in which HPC could 
potentially protect skeletal muscle against IRI following TKR specific tourniquet 
application. Therefore, a reduction in redox mediated tissue damage could lead to 
less wound complications and greater surgical outcomes (Soneja et al., 2005; 
Estebe et al., 2011).    
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Mice kept in normobaric hypoxic (10% O2) chambers for 4 hrs followed by 24 hrs 
in normoxia prior to 20 min global cardiac ischemia and 30 min reperfusion, 
displayed a reduction in infarct size in comparison to control mice in isolated 
hearts (Xi et al., 2002). Furthermore, HPC prior to 6 hrs of hypoxia (0.5% O2) and 
12 hrs re-oxygenation provided a significant reduction in apoptosis of 
mesenchymal cells in-vitro (Wang et al., 2008). Further in-vitro work by Wu et al. 
(2013) illustrated that 20 min of HPC simulated by incubation in anoxia (95 % N, 
5% CO2) 24 hrs prior to 3 hrs of anoxia induced a reduction in ECs apoptosis. 
Animal in-vivo research by Berger et al. (2010) performed 4 hrs of systemic 
normobaric hypoxia at different concentrations (8%, 12% and 16% O2) in rats. 
The author noted a significant reduction in infarct size in all HPC condition in 
comparison to control.  
In summary, IPC has been shown on numerous occasions to diminish the 
deleterious effects of IRI in a multitude of tissues, with similar results observed in 
HPC. However, there is a lack of research regarding the effects of HPC in human 
in-vivo skeletal muscle and circulation following TKR specific tourniquet 
mediated limb ischemia.  
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Chapter 3: Methodology  
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3.1 Participants 
Eighteen recreational healthy male participants were recruited for the study (see 
Table 3.1 for demographic data). Prior to experimental contribution, participants 
were all informed of the procedure and the risks involved in participating, 
subsequently providing written informed consent, according to the principles set 
out in the Declaration of Helsinki (Appendices B - E). Each participant was 
medically screened and ethical approval was obtained via the University of 
Bedfordshire’s, Sport and Exercise Science Department Human Ethics 
Committee. It was mandatory that participants were free from any 
musculoskeletal injury or acute or chronic sickness, in addition to abstinence from 
medication (vitamin supplementation), ergogenic aids (creatine, ß-alanine,) and 
extreme environments (hyperthermia, hypoxia) that may affect any variables 
intended to be measured in this study. All participants were non-smokers and 72 
hours prior to testing, participants were required to refrain from alcohol, caffeine 
and exercise (the full list is available in Appendix A). Participants were randomly 
allocated into either control (SHAM), hypoxic preconditioning (HYP) or ischemic 
preconditioning (TOR) conditions. 
3.2 Anthropometric Data 
Body mass (kg), and height (m) were assessed with the use of a Digital Tanita 
scales (BWB0800, Allied Weighing, UK) and a wall-mounted Stadiometer 
(Holtain Ltd, UK) respectively. Participants were asked to refrain from fluid/food 
ingestion 4 hours, in addition to an evacuated bladder immediately prior to 
estimation of percentage muscle and fat mass (%) through utilisation of air 
51 
 
pletysmography (BodPod 2000A, Cranlea, UK). Furthermore, individual’s blood 
pressure was noted in triplicate and an average was obtained (M5-I, Omron, 
Cranlea, UK). Participants were seated for 5 min and requested to close their eyes 
and relax prior to measurement acquisition based on the manufacturer’s 
instructions. Finally, thigh circumference was obtained in triplicate using a tape 
measure (Body Care, HaB Direct, UK) at 40% of the distance from the knee joint 
centre to the greater trochanter on the right leg (Table 3.1).  
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Table 3.1: Participant demographic data   
Measure SHAM     HYP     TOR     
  
Mean SD Range Mean SD Range Mean SD Range 
Age (years) 22.2 2.9 18 - 26 20.8 2.4 19 - 25 18.5* 0.6 18 - 19 
Height (m) 1.83 0.06 1.75 - 1.92 1.77 0.10 1.67 - 1.93 1.79 0.04 1.73 - 1.83 
Mass (kg) 80.4 12.4 62.8 - 93.4 73.5 8.7 61.9 - 86.6 76.7 7.8 64.8 - 87.4 
Lean mass (%) 85.8 3.5 79.3 - 88.5 84.9 5.3 78.9 - 91.4 86.5 3.0 81.5 - 90.1 
Fat mass (%) 14.2 3.5 11.5-20.7 15.3 5.5 8.6 - 22.1 13.5 3.0 9.9 - 18.5 
Thigh Circumference (cm) 44.7 2.6 40 - 47 42.8 2.1 40 - 46 43.3 2.4 39 - 46 
Systolic Blood Pressure 
(mmHg) 
124.0 3.0 120 - 129 125.8 1.9 123 - 129 125.5 2.1 123 - 129 
Diastolic Blood Pressure 
(mmHg) 
76.2 7.0 65 - 83 75.0 6.0 65 - 81 79.7 8.0 70 - 92 
* Significant difference v.s. SHAM (p < 0.05) 
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3.3 Hydration Status Assessment 
Dehydration has the potential to induce oxidative stress (Paik et al., 2009), which 
in turn initiates regulation of HSPs (Ahn and Thiele, 2003). Therefore, the author 
felt it necessary to assess hydration status prior to commencing the trials in order 
to minimise erroneous results. Urine refractormetry has been previously shown to 
provide a reliable measure for urine specific gravity to assess hydration status 
(Stuempfle and Drury, 2003).  
Upon arrival to the laboratory, participants were requested to provide a urine 
sample for analysis via a urine refractometer (Pocket Pal-Osmo, Atago Vitech 
Scientific, HAB Direct, UK). Samples were assessed in triplicate and 
euhydratrion was accepted at 200-600 mOsmols∙kgH2O
-1 
utilised previously by 
(Hillman et al., 2011) 
3.4 Blood Collection 
Blood samples were obtained using Vasoplus Needles (22G x 1 ½”, Grenier Bio-
One, UK) from the antecubital region via standard venepuncture techniques 
(Figure 3.1). Samples were drawn directly into three separate vacuette containers 
(Vacuette®, Grenier Bio-One, UK) treated with K3EDTA (HSP gene expression 
(Hsp)), sodium citrate (TGSH, GSSG) or lithium heparin (PC).  
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The author originally proposed to acquire blood samples from the ischemic lower 
leg, in addition to blood from the antecubital region, as previous research (Karg et 
al., 1997; Garcia-de-la-Asuncion et al., 2012) has shown differing metabolite 
concentrations in systemic and localised blood following limb ischemia. 
However, following pilot-work, it was established that obtaining blood from the 
lower leg was not possible and only systemic blood was collected thereafter.  
 
 
 
Figure 3.1: Image of the venepuncture technique used during the study.  
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3.4.1 K3EDTA Treated Blood 
 
Blood treated with the anti-coagulant EDTA has been demonstrated to increase 
the yield of Hsp concentrations in comparison to alternative method (Whitham 
and Fortes, 2006). Leukocytes were isolated utilising an adaptation of a technique 
previously validated (Sandstrom et al., 2009; Taylor et al., 2010; Hillman et al., 
2011).  
Briefly, 1 mL of K3EDTA blood was added to 1:10 eythrocyte lysis solution 
(Miltenyi Biotec, UK) and allowed to incubate at room temperature for 15 min, 
prior to isolation via centrifugation at 400 G for 5 min at 4°C. Supernatant was 
removed and the remaining pellet was washed with 2 mL of phosphate buffered 
saline (PBS) solution (Fisher Scientific, UK) then centrifuged at 400 G for 5 min 
at 4°C. Supernatant was discarded and a repeat wash was performed. The pellet 
was suspended in 1 mL of PBS and separated equally into two 1.5 mL RNase free 
eppendorfs then centrifuged at 17 000 G for 5 min at 4°C. The remaining 
supernatant was aspirated prior to the pellet being completely re-suspended in 200 
µL of TRIzol reagent (Sigma Aldrich, Dorset, UK) and stored at -80°C for 
subsequent RNA extraction (section 3.10). 
3.4.2 Sodium Citrate Treated Blood 
Two mL of sodium citrate blood was immediately added to 8 mL of freshly 
prepared 5% metaphosphoric (Sigma Aldrich, Dorset, UK) and left to incubate on 
ice for 15 min before being centrifuged at 12 000 G for 15 min at 4°C. The 
clarified supernatant was collected and separated into 1.5 mL eppendorfs prior to 
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storage at -80°C until future analysis for TGH and GSSG with commercially 
available kits (section 3.9).     
3.4.3 Lithium Heparin Treated Blood 
The collected blood was immediately centrifuged at 900 G for 10 min at 4°C 
before the plasma was separated into 1.5 mL eppendorfs and stored at -80°C until 
future analysis via commercially available kits (section 3.8). 
3.5 Muscle Biopsies 
Muscle Biopsies were obtained from the lateral head of the gastrocnemius of the 
ischemic leg 2 cm apart under local anaesthetic (2% lidocaine hydrochloride), 
specifically avoiding the fascia of the muscle as outlined by Trappe et al. (2013), 
using a disposable biopsy needle (Figure 4.2) (12 x 16, Disposable Monopty Core 
Biopsy Instrument, Bard Biopsy Systems, USA) and placed into 2 mL RNase free 
tubes (detailed method in Appendix F). Multiple sample sites were elected as 
previous research has shown multiple passes from a single incision can alter tissue 
gene expression (Friedmann-Bette et al., 2012). Samples collected (20-30 mg) 
were immediately frozen in liquid nitrogen (-196°C) and stored at -80°C for 
subsequent RNA extraction (see section 3.10). Serial muscle biopsies have been 
previously demonstrated not to provoke stress proteins in the residual tissue 
(Khassaf et al., 2001).    
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3.6 Experimental Design 
Participants arrived at the University of Bedfordshire’s Sport and Exercise 
Laboratories for two separate visits at 11:30. The laboratories were maintained at 
a constant temperature (mean ± SD; 22 ± 1°C) throughout the entire experiment. 
The first visit was used to provide anthropometric data as outlined in section 3.2 
and occurred between 7-14 days prior to the second visit. Participants were 
Figure 3.2: Images of the muscle biopsy procedure. (A) The 
gastrocnemius was cleaned with cyclohexane, injected with lidocaine 
subsequently a small incision was made. (B) 20-30 mg of tissue was 
obtained using Bard Biopsy needle.  
 
A 
B 
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requested to consume a standardised meal in the evening prior to their second 
visit.     
Upon arrival to the laboratories for the second time, participants were requested to 
provide a urine sample and abstinence information as depicted by section 3.3 and 
3.1 respectively, in addition to providing a food diary for the past 3 days 
ingestion. Participants were positioned in an inclined supine position throughout 
the trial and asked to move as little as possible. Participants were permitted a 
standardised breakfast and lunch 3 hrs prior to commencing the trial and 2 hrs into 
experiment respectively. Compliance was monitored via a questionnaire. The 
author would have preferred participants to be fasted for 6 hrs and be nil-by-
mouth for the duration of the trial to simulate hospital protocol. However, pilot-
work demonstrated that due to the invasive nature of the study, individual’s 
suffered from bouts of syncope during the muscle biopsy procedure, thus making 
this unethical.  
All participants were initially rested for 1 hour prior to undertaking their allocated 
40 min preconditioning intervention. Individuals in the SHAM condition received 
an extended rest period. HYP inhaled 14.3% O2 (2, 980 m above sea level) in 
normobaric pressure via an adjustable hypoxicator (Everest Summit II, The 
Altitude Centre, UK), which has been shown to be an adequate stimulus to induce 
a cellular stress response in-vivo (Taylor et al., 2010). The hypoxicator produces 
the necessary hypoxic load via O2 filtration. During the hypoxic exposure, 
participants heart rate (HR) and oxyhaemoglobin saturation were measured every 
5 min via finger pulse oximetry (Onyx® II 9550, Nonin Medical, USA). TOR 
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received 4 cycles of 5 min ischemia and 5 min reperfusion at 100 mmHg above 
the participant’s systolic pressure on their right leg. The chosen pressure was 
based upon previous research by Estebe et al. (2000), with the duration of 
ischemic cycles adapted from work by Koca et al. (2011). All ischemic bouts 
throughout were produced via a straight 10 cm wide tourniquet cuff (AET, Anetic 
Aid, Leeds, UK) positioned superiorly to cotton wool padding (Estebe et al., 
2011), with pressure maintained by means of an electronic tourniquet unit (AET, 
Anetic Aid, Leeds, UK). 
Upon cessation of the preconditioning intervention, participants rested again for 1 
hour prior to a 5 min 45° limb elevation, immediately followed by a 30 min 
tourniquet application (100 mmHg above resting systolic pressure) on the right 
leg and a 2 hour period of reperfusion. The tourniquet pressure of 100 mmHg 
above systolic was elected as it is sufficient to provide a bloodless field while 
reducing the likelihood of associated negative side-effects (Worland et al., 1997).            
Blood samples were obtained at Basal, immediately post intervention (PoI), 
immediately pre-tourniquet application (PrT), 15 min post-tourniquet removal 
(15PoT) and 120 min post tourniquet removal (120PoT) utilising the procedure 
and controls outlined in section 3.4, with the addition of muscle samples collected 
at PrT, 15PoT and 120PoT in accordance with section 3.5 (Figure 4.3).   
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3.7 Muscle Sample Preparation 
Muscle samples were ground under liquid nitrogen prior to homogenisation (T10 
Basic, IKA, Thermo Fisher Scientific, Loughborough, UK) on ice in 1 mL TRIzol 
reagent followed by a 10 min incubation period on ice. RNA was extracted 
utilising the method described in section 3.10.     
3.8 Protein Carbonyl Quantification 
PC is a widely accepted measure of protein oxidation (Powers et al., 2010b) and 
has been cited as more stable marker of oxidised structural modifications in 
Tourniquet Ischemia 
Recovery Hypoxic Exposure Reperfusion 
No preconditioning 
TOR Condition 
HYP Condition 
SHAM Condition 
Time (min) 
14:55 11:30 12:30
0 
13:10 14:10 14:40
0 
16:55 
Basal PoI PrT 15PoT 120PoT 
Figure 3.3: Experimental design for all conditions.  Blood samples (↑) were 
obtained at Basal, PoI, PrT, 15PoT and 120PoT with additional 
gastrocnemius tissue ( ) collected at PrT, 15PoT and 120PoT. 
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comparison to the more commonly used transient measures of MDA (Pantke et 
al., 1999), therefore, this particular marker was chosen and analysed using 
commercially available kits (Protein Carbonyl Colorimetric Assay Kit, 10005020, 
Caymen Chemical Company Company, Michigan, USA).  
Two hundred µL of pre-treated lithium heparinised plasma (section 3.4.3) was 
added to 800 µL of 2,4-dinitrophenylhydrazine acting as the sample tube while 
200 µL of plasma was added to 800 µL of 2.5 M hydrochloric acid to serve as the 
control tube. All tubes were required to incubate in the dark for 1 hour at room 
temperature with a brief vortex every 15 min. 1 mL of 20% trichloroacetic acid 
(TCA) was added to each tube, briefly vortexed and incubated on ice for 5 min 
prior to centrifugation at 10 000 G for 10 min at 4°C. This was followed by a 10% 
TCA wash, incubation on ice for 5 min and centrifuged at 10 000 G for 10 min at 
4°C. Supernatant was discarded and the pellet suspended in a 1:1 ethanol/ethyl 
acetate wash before undergoing a thorough vortex and centrifugation at 10 000 G 
for 10 min at 4°C. This was repeated twice more before the pellet being re-
suspended in 500 µL of guanidine hydrochloride and centrifuged at 10 000G for 
10 min at 4°C. An aliquot of 220 µL of both sample and control was added to a 
96-well plate and the absorbance was measured at 360 nm using a microplate 
reader (Sunrise™, Tecan, Reading, UK). All samples and standards were analysed 
in duplicate. 
PC concentration was analysed using the subsequent equation: 
   (         )   
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Corrected absorbance (CA) was produced through the subtraction of the average 
control absorbance from the average sample absorbance with 500 µL/200 µL 
providing the original sample concentration and 0.011 µM
-1
 as the actual 
extinction coefficient for 2,4-dinitrophenylhydrazine at 370 nm. The intra and 
inter-assay coefficient of variance are 4.7% and 8.5% respectively. 
To assess the protein content of the sample, a 1:10 dilution of sample control to 
gunadine hydrochloride was prepared, the absorbance was determined at 280 nm 
using a Nanodrop 2000c (Thermo Fsiher Scientific, Loughborough, UK) and 
calculated from a bovine serum albumin standard (0.25-2.0 mg∙mL-1) curve using 
the following equation: 
                       (       )  (
                 
     
)          
The final assessment of carbonyl content is produced via the subsequent equation:  
                 (         )   
         (          )
        (       )
 
3.9 Glutathione Analyses 
Glutathione has been reported to provide a useful marker for disturbances to the 
redox balance (Powers et al., 2010b). The most commonly used technique is high 
performance liquid chromatography; however, this involves large quantities of 
time pre- and post-assay procedure (Asensi et al., 1994) and can involve varying 
degrees of GSH recovery (Ostman et al., 2004). Spectrophotometric techniques 
are often utilised via verification of glutathione in the ‘recycling method’ of 
Ellman’s reagent (5,5′-dithio-bis-2-nitrobenzoic acid (DTNB)) and GSH 
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measuring absorbance at 412 nm; providing convenience, sensitivity and accuracy 
in various sample types (blood, urine, muscle, liver) (Rahman et al., 2006), thus 
for these reasons, this method was chosen for this research project.  
To determine the concentration of TGH previously treated blood (50 µL; section 
3.4.3) was diluted to 1:40 with assay buffer solution and transferred to a 96-well 
plate in accordance with the manufacturer’s instructions (Glutathione (Total) 
Detection Kit, ADI-900-160, Enzo Life Sciences, Exeter, UK). A standard curve 
was created through serially diluting 50 µL GSSG standard and 50 µL of assay 
buffer solution (100-12.5 pmol). A 150 µL mixture of DTNB and 10 µL 
glutathione reductase was added to all wells to produce 5-thio-2-nitrobenzoic acid 
(TNB) which measured absorbance at 405 nm in a microplate reader (Sunrise™, 
Tecan, Reading, UK) every minute for 10 min. For determination of GSSG, the 
method outline above was replicated with the addition of samples first being 
treated with 1 µL of 2M 4-Vinylpyridine (Sigma Aldrich, Dorset, UK) to block 
any free thiols from cycling the reaction. 4 µL of 2M 4-Vinylpyridine was added 
to 200 µL of GSSG standard to produce a standard curve. Samples and standards 
were incubated for 1 hr and analyses were identical to the protocol for TGH. 
Reduced glutathione was calculated via subtraction of GSSG concentrations from 
TGH and a final GSH/GSSG ratio was computed. All standards and samples were 
run in triplicate and an average was taken. The intra- and inter-coefficient of 
variance for the assay kits was 3.4% and 3.6% respectively.  
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3.10 RNA extraction 
RNA was extracted using previously validated methods (Chomczynski and 
Sacchi, 1987). Briefly, chloroform (Sigma Aldrich, Dorset, UK) was added to 
(200 µL for muscle samples; 40 µL for leukocytes samples) samples suspended in 
TRIzol® reagent, then vortexed and left to incubate on ice for 10 min prior to 
centrifugation at 17 000 G for 15 min at 4°C. The resulting sample separates into 
an aqueous clear phase containing RNA and chloroform; a small white interphase 
comprising of DNA and protein; and a large pink phase containing TRIzol and 
cellular remnants. The aqueous phase was carefully aspirated into a fresh 1.5 mL 
RNA-free eppendorf and equal volume of ice-cold propan-2-ol (Sigma Aldrich, 
Dorset, UK) was added before a 15 min incubation period on ice and subsequent 
centrifugation at 17 000 G for 15 in at 4°C. The supernatant was removed and the 
sample was washed with ice-cold 75% ethanol (Sigma Aldrich, Dorset, UK) (1 
mL for muscle samples; 100 µL for leukocytes samples) ahead of centrifugation at 
5 400 G for 8 min at 4°C. Two additional ethanol washes were performed. 
Remaining ethanol was aspirated and the pellet was allowed to air dry for 5 min 
prior to the addition of 50 µL of RNA storage solution (Invitrogen, Paisley, UK), 
followed by a final vortex for 90 s.  
All procedures outlined above were performed using RNA-free pipette tips and 
pipettes that were solely used for RNA work, on surfaces and equipment which 
had been decontaminated with 70% industrial methylated spirit and RNase ZAP 
(Ambion, The RNA Company Cheshire, UK) prior to commencement of RNA 
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work. Fresh tips were used for each sample to avoid sample cross-contamination. 
The samples were frozen at -80°C for future RNA concentration quantification.  
3.11 RNA concentration quantification  
RNA concentrations and purity were calculated by spectrophotometry analysis 
utilising the Nanodrop 2000c. 2 µL of RNA storage solution was placed onto the 
pedestal as the blanking solution prior to sample measurement. Subsequently, 1µL 
of sample was placed onto the pedestal and measured at wavelengths of 260 nm 
and 280 nm. The ratio of 260/280 was used to assess the purity of the RNA 
sample, where the ratio 2.0 was considered to be “pure” RNA. Samples were 
considered “high quality” at ratios in the range of 1.90 – 2.10 and were accepted 
for use in quantitative real-time polymerase chain reaction (RT-PCR). 
Concentrations of RNA were calculated using a modification of the Beer-Lambert 
equation: 
  (       )   
  (  )    (         )
  (  )
 
Where c is the nucleic acid concentration; A is the absorbance; ε is the 
wavelength-dependant extinction coefficient (40 ngcm·µL
-1
 for RNA); and b is 
the pathlength. 
3.12 One-step quantitative real-time polymerase chain reaction 
RT-PCR was performed on a thermal cycler (RotorGene, Qiagen, Manchester, 
UK) using QuantiFast® SYBR® Green RT-PCR kits (Qiagen, Manchester, UK) 
containing: (2x) QuantiFast SYBR Green RT-PCR Master Mix (HotStarTaq® 
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plus DNA Polymerase, Quanitfast SYBR green RT-PCR buffer, dNTP mix 
(dATP, dCTP, dGTP, dTTP), ROX passive reference dye) and (1x) QuanitFast 
reverse transriptase (RT) mix (Omniscript® RT, Sensiscript® RT). 
Primers in Table 3.2 were designed by Sigma Aldrich (Dorset, UK). 20 µL of 
reaction mix (10 µL of SYBR green, 0.15 µL forward primer, 0.15 µL reverse 
primer, 0.2 µL reverse transcriptase, 9.5 µL of sample (70 ng∙µL-1 of RNA)) was 
distributed using an automated pipetting machine (QiAgility, Qiagen, Manchester, 
UK).  
The amplification program involved a preliminary denaturation phase at 50°C for 
10 min followed by further holding at 95°C for 5 min. Samples then undertook 40 
cycles of denaturation lasting 10 s at 95°C with a subsequent annealing and 
extension phase for 30 s at 60°C. SYBR green fluorescence was measured after 
each cycle. Melting curve analysis was then performed concluding the 40 cycles, 
where samples were incubated at 50°C and heated to 99°C with the fluorescence 
measured every 1°C increase. All samples were performed in duplicate.   
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Table 3.2: Primer Sequences
 
Target Gene Primer Sequence (5'-3'-) 
Reference 
Sequence 
Number 
Amplic
on 
Length 
(bp) 
GC% 
Content 
B2 
microglobuli
n 
Forward: 
CCGTGTGAACCATGTGAC
T 
NM_0040
48 
19 52.63 
 
Reverse: 
TGCGGCATCTTCAAACCT  
18 50.00 
HSP 72 
Forward: 
CGCAACGTGCTCATCTTT
GA 
NM_0053
45 
20 50.00 
 
Reverse: 
TCGCTTGTTCTGGCTGATG
T 
 
20 50.00 
HSP32 
Forward: 
CAGCAACAAAGTGCAAGA
T 
NM_0021
33 
19 42.11 
  
Reverse: 
CTGAGTGTAAGGACCCAT
C 
  19 52.63 
 
3.12 Quantitative real-time polymerase chain reaction analyses 
Samples displaying multiple peaks in the melting curve were excluded from 
further analyses. RotorGene software plotted the sample fluorescence against 
cycle number on a graph and the cycling threshold was manually positioned above 
background fluorescence levels where there was an exponential rise in 
fluorescence. Gene expression was determined through the ratio between the 
target gene and the housekeeping gene, ß2-microglobulin, and was calculated 
using the comparative threshold cycle (2
-ΔΔCT
) method (outlined by Schmittgen 
and Livak (2008)), where relative gene expression was determined using 2
-ΔΔCT
 . 
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3.13 Statistical Analyses 
All data was analysed using the statistical software package IBM SPSS version 
19.0 (SPSS Inc, Chicago IL, USA). Prior to any performance of inferential 
statistics, descriptive tables and graphical methods (Q-Q plots and scatter plots) 
were utilised to check for statistical assumptions. All data presented was deemed 
to be normally distributed. A number of outliers were observed during exploratory 
data analysis and were subsequently removed prior to performance of inferential 
statistics (n = 6 in each condition unless otherwise stated). A one-way analysis of 
variance (ANOVA) was used to assess for statistical differences between 
participants’ anthropometric data. A one-way repeated measures ANOVA was 
utilised to establish significant differences between haemoglobin saturation and 
HR during the hypoxic intervention period. Sphericity was assumed for all 
repeated measures analysis. Linear mixed models (LMMs) were used to identify 
significant group x time interactions in the remaining dependant variables across 
all groups. In the event of a significant F ratio for both LMMs and one-way 
repeated measures ANOVAs, the post-hoc test Sidak was used to locate 
significant pairs. LMMs were chosen as this particular type of statistical analyses 
allows for missing data, for non-independent data and the best appropriate 
covariant structure to be selected (Field, 2009). The most suitable covariant model 
was decided using the difference in -2 restricted log likelihood figures and the 
number of parameters of the two models tested against the χ2 critical statistic 
(Field, 2009). Furthermore, residuals were checked for normality and 
homogeneity of variance using Q-Q plots and scatter plots respectively, and were 
considered plausible for all dependant variables. Statistical significance was 
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assumed at p < 0.05. Finally, Cohen’s effect sizes (ESs) for independent means 
were calculated utilising the formula outlined by Cohen (1992): 
   
     
 
 
The quantity d is the standardised mean difference, where µa and µb are separate 
means. The value σ is the pooled standardiser and is computed using the 
subsequent equation described by Olejnik and Algina (2000): 
    √
(    )  
 
 
 
 (    )  
 
 
 
(    )  (    )
 
The quantities na, SDa and nb, SDb represent the sample size and SD for µa and µb 
respectively. The ES was established as: small (d = 0.2), medium (d = 0.5) and 
large (d = 0.8) effects (Cohen, 1992).   
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Chapter 4: Results  
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No significant differences (p ≥ 0.34) in participant demographics were observed 
between SHAM, HYP or TOR, with the exception of age (F2,15 = 4.36, p = 0.32) 
noted between conditions TOR and SHAM  (p = 0.032) (Table 3.1). 
A significant main effect displayed a decrease in haemoglobin saturation (F8,40 = 
17.331, p < 0.001) between baseline and all subsequent time points (p < 0.05) in 
the HPC intervention experienced by HYP. However, there was no significant 
main effect (F8,40 = 1.130, p = 0.365) in HR noted by the same exposure (Figure 
4.1).   
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Figure 4.1: Mean HR and oxyhaemoglobin saturation during 
HYP intervention. * indicates significant difference v.s. 
baseline value. Error bars represent SD. Abbreviations: HR – 
heart rate 
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4.1 Circulatory stress and redox markers  
There were no significant (p > 0.05) group x time interaction effects for leukocyte 
Hsp72 (F = 1.195, p = 0.347), leukocyte Hsp32 (F = 1.406, p = 0.244), PC (F = 
0.681, p = 0.707), TGH (F = 0.510, p = 0.844), GSSG (F = 0.510, p = 0.844), 
GSH (F = 0.856, p = 0.564) or GSH/GSSG (F = 1.959, p = 0.105) (Table 4.1). 
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Table 4.1: Mean (SD) systemic circulatory stress and redox markers across basal, immediately post-intervention (PoI), immediately pre-
tourniquet application (PrT), 15 min post-tourniquet removal (15PoT) and 120 min post-tourniquet removal (120PoT)  
Measure Basal PoI PrT 15PoT 120PoT 
  
SHAM HYP TOR SHAM HYP TOR SHAM HYP TOR SHAM HYP TOR SHAM HYP TOR 
Hsp72 (relative 
fold change from 
basal) 
1.46 
(0.42) 
1.29 
(0.39) 
1.72 
(0.54) 
1.46 
(0.55) 
1.23 
(0.44) 
1.31 
(0.17) 
1.43 
(0.41) 
1.45 
(0.36) 
1.31 
(0.35) 
1.44 
(0.43) 
1.57 
(0.31) 
1.33 
(0.14) 
1.23 
(0.44) 
1.35 
(0.27) 
1.35 
(0.21) 
Hsp32 (relative 
fold change from 
basal) 
1.34 
(0.43) 
1.08 
(0.24) 
1.47 
(0.55) 
1.09 
(0.33) 
1.14 
(0.24) 
1.23 
(0.40) 
0.86 
(0.14) 
1.10 
(0.28) 
1.29 
(0.29) 
0.86 
(0.28) 
1.24 
(0.27) 
1.17 
(0.33) 
1.04 
(0.45) 
1.02 
(0.41) 
1.08 
(0.38) 
Protein Carbonyl 
(nmol·mL
-1
) 
0.56 
(0.14) 
0.56 
(0.19) 
0.69 
(0.24) 
0.54 
(0.16) 
0.42 
(0.13) 
0.61 
(0.13) 
0.64 
(0.13) 
0.58 
(0.08) 
0.69 
(0.21) 
0.65 
(0.18) 
0.60 
(0.24) 
0.56 
(0.15) 
0.65 
(0.32) 
0.69 
(0.15) 
0.63 
(0.21) 
Oxidised 
glutathione 
(pmol) 
190 
(87) 
155 
(70) 
177 
(96) 
178 
(70) 
135 
(34) 
140 
(35) 
166 
(52) 
150 
(63) 
216 
(127) 
174 
(50) 
216 
(56) 
173 
(69) 
205 
(83) 
202 
(75) 
208 
(97) 
Reduced 
glutathione 
(pmol) 
3815 
(603) 
4441 
(598) 
4081 
(607) 
3874 
(653) 
5218 
(895) 
4431 
(520) 
4021 
(557) 
4256 
(998) 
4397 
(614) 
4386 
(366) 
4163 
(720) 
4389 
(864) 
4224 
(390) 
4280 
(585) 
4353 
(870) 
Reduced/oxidised 
glutathione ratio 
23.0 
(9.1) 
31.4 
(12.2) 
22.7 
(8.6) 
24.6 
(9.6) 
29.3 
(5.4) 
28.9 
(7.4) 
27.1 
(11.6) 
23.9 
(7.3) 
18.6 
(7.6) 
27.6 
(10.7) 
20.5 
(3.6) 
23.1 
(8.7) 
23.0 
(7.7) 
22.4 
(2.2) 
20.5 
(9.6) 
Total glutathione 
(pmol) 
4006 
(646) 
4596 
(650) 
4258 
(580) 
4052 
(649) 
4352 
(936) 
4434 
(561) 
4187 
(532) 
4358 
(888) 
4596 
(555) 
4374 
(557) 
4343 
(797) 
4563 
(828) 
4395 
(462) 
4488 
(580) 
4625 
(399) 
Hsp – heat shock protein gene expression
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4.2 Localised muscle stress markers  
Hsp72 gene expression 
Significant group x time interaction effects (F = 3.058, p = 0.048) were observed 
in muscle Hsp72 relative gene expression. There was a 76% mean increase 
between PrT and 15PoT (95% CI -3.771, -0.124; p = 0.035) in SHAM displaying 
a large ES (1.44). Also, a pronounced 116% increase between PrT and 120PoT 
(95% CI -3.779, -0.400; p = 0.014) was noted in TOR also producing a large ES 
(1.59). Furthermore, there was a 51% and 50% decrease in HYP (95% CI 0.634, 
3.934; p = 0.007) and TOR (95% CI 0.675, 4.114; p = 0.006) respectively when 
compared to SHAM at 15PoT both demonstrating large ESs (1.90 and 2.19 
respectively) (Figure 4.2). (SHAM, n = 5; HYP, n = 6; TOR, n = 6). 
  
Figure 4.5: Hsp72 relative gene expression
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Figure 4.2: Mean muscle Hsp72 relative gene expression at 
immediately pre-tourniquet application (PrT), 15 min p st-
tourniquet removal (15PoT) and 120 min post-tourniquet 
removal (120PoT) in all conditions. Like letters denote 
significant differences (p < 0.05) between mean values. Error 
bars represent SD. 
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Hsp32 gene expression 
There were no significant group x time interactions (F = 0.147, p = 0.961) in 
muscle Hsp32 gene expression over PrT, 15PoT and 120PoT (Figure 4.3) 
(SHAM, n = 5; HYP, n = 6; TOR, n = 6). 
 
  
Figure 4.6: Hsp32 relative gene expression
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Figure 4.3: Mean muscle Hsp32 relative gene expression at 
immediately pre-tourniquet application (PrT), 15 min post-
tourniquet removal (15PoT) and 120 min post-tourniquet 
removal (120PoT) in all conditions. No significant 
interaction effects were noted at any time point Error bars 
represent SD. 
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Chapter 5: Discussion 
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The purpose of the present study was to examine whether HPC and IPC elicited a 
reduction in oxidative stress to knee surgery specific tourniquet application. 
Furthermore, to elucidate a time-course for circulatory oxidative stress markers 
(GSH, GSSG, GSH/GSGG ratio, PC); in addition to circulatory (leukocyte) and 
localised (muscle) stress protein expression (Hsp72 and Hsp32). In contrary to the 
hypothesis, the results revealed that a bout of either HPC or IPC did not produce a 
statistically significant reduction in systemic Hsps, redox stress markers, or in 
localised Hsp32 in comparison to control. However, both HPC and IPC did 
demonstrate a significant reduction in Hsp72 at 15PoT in the localised 
gastrocnemius tissue from TKR specific tourniquet application. 
5.1 Circulatory redox and stress markers 
Interestingly, the intervention groups did not display a significant difference in 
oxidative stress markers in comparison to the control following TKR specific 
tourniquet application. This is in disagreement with Koca et al. (2011) who 
observed stable redox markers (malondialdehyde (MDA), total oxidant and 
antioxidant capacity) in the IPC group in comparison to a significant negative 
response noted in control following knee arthroscopy surgery. However, the 
authors failed to implement any subject dietary restrictions, which could have 
markedly affected the subjects’ antioxidant capacity (Powers et al., 2010b) and 
could potentially have impacted upon the results published. Furthermore, smoking 
has been shown to increase ROS production (Kalra et al., 1991), however, Koca 
and colleagues (2011) did not exclude smokers from their research, thus the 
experimental findings displayed may not be a true representation of their 
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experimental manipulation. Finally, the measure of MDA via thiobarbituric acid 
assay utilised by Koca et al. (2011) is considered to be an unacceptable measure, 
as the majority of thiobarbituric acid material found in the body is not related to 
MDA (Powers et al., 2010b), perhaps explaining the differing redox results 
between the current study.      
It could be speculated that the 30 min bout of limb ischemia utilised here did not 
induce a sufficient level of stress to observe the hypothesised potential favourable 
effects bestowed from the preconditioning interventions in the systemic blood. 
Previous surgical literature demonstrating the beneficial effects of IPC through 
circulatory markers implemented a far greater ischemic periods (mean ± SD; 89 ± 
9 min (Koca et al., 2011)). This extended ischemic period would induce greater 
quantities of activated leukocytes and ROS into the circulation, thus stimulating 
further cellular structure oxidation. Therefore, without the initial systemic 
oxidative burst, preconditioning would not provide a noticeable benefit. Indeed, 
this hypothesis is reinforced via the stable leukocyte stress response (Hsp) data 
depicted in Table 4.1.  
HSPs are up-regulated during a variety stressors, such as oxidative stress, hypoxia 
and ischemia (Morton et al., 2009). The homeostatic insults lead to protein 
denaturation and unfolding, initiating the heat shock response, thus permitting 
heat shock factor 1 (HSF1) to oligermerise and bind to the heat shock element 
promoting gene transcription (Noble et al., 2008). HSP72 provides cytoprotection 
through refolding of denatured proteins and rescuing apoptotic cells via 
interruption of the programmed death cascade (Taylor et al., 2011). An increase in 
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Hsp72 would demonstrate greater cellular stress (Theodorakis et al., 1999), 
however, as aforementioned; no significant increases in leukocyte Hsp72 were 
noted in peripheral blood in any of the conditions following the TKR specific 
tourniquet application (Table 4.1). Therefore, it could be inferred that there was 
no systemic stress following 30 min limb ischemia.   
Surprisingly, there were also no significant changes in leukocyte Hsp72 
concentration at PoI in HYP or TOR following the preconditioning (Table 4.1). A 
rise in Hsp72 following HPC or IPC would be expected as the initiation of both 
interventions invokes an oxidative burst (Konstantinov et al., 2004; Taylor et al., 
2010), thus stimulating the heat shock response. In contrast to the results in the 
current study, Konstantinov et al. (2004) showed an increase in peripheral 
leukocyte Hsp72 using microarray analyses following IPC in the forearm. 
Although the authors observed a rise in leukocyte Hsp72, there is evidence to 
suggest that microarray analyses can overestimate gene expression (Feldman et 
al., 2002). Furthermore, Taylor et al. (2010) noted a significant increase in Hsp72 
following an acute hypoxic exposure, which again is in contrary to the data 
following HPC (Table 4.1). The disparity between Taylor et al. (2010) and the 
present study may be due to the longer hypoxic period utilised by the authors, thus 
providing greater systemic stress to induce a larger up-regulation in Hsp72.  
Both Taylor et al. (2010) and Konstantinov et al. (2004) used different techniques 
(flowcytometry and microarray respectively) of quantifying the changes in stress 
protein response in comparison to the present study (RT-PCR). However, 
measurement of gene expression via RT-PCR is considered to be a sensitive and 
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reproducible method in which to quantify gene expression (Wong and Medrano, 
2005), as such, would be able to identify the appearance of small changes in gene 
expression.  
A rise in leukocyte Hsp32 would be anticipated following an oxidative stress 
insult (Fehrenbach et al., 2003). The rapid induction of HSP32 has been proposed 
to stimulate protection via the catabolism of the reactive free heme into carbon 
monoxide and biliverdin (Gozzelino et al., 2010). However, the present study did 
not observe a significant increase in leukocyte Hsp32 (Table 4.1). Despite the 
evidence depicting the vital role HSP32 plays in counteracting oxidative stress 
(Gozzelino et al., 2010), no previous research has assessed Hsp32 with regards to 
human limb ischemia in-vivo. Therefore, this finding (stable systemic Hsp32 
concentrations following preconditioning and limb ischemia) can be considered 
novel.  
Glutathione concentrations have been previously measured in the systemic blood 
following TKR surgery (Mathru et al., 1996; Karg et al., 1997). Interestingly, both 
Karg et al. (1997) and Mathru et al. (1996) only observed changes in GSSG 
immediately following reperfusion in the localised blood supply rather than the 
systemic circulation. The observation of stable systemic glutathione markers is in 
accordance with the present study’s findings (Table 4.1). This would suggest that 
the localised circulation offered protection to the remote blood supply from 
potentially damaging ROS. Indeed, it has been shown that intact erythrocytes 
scavenge H2O2, providing vital protection to distant organs (Toth et al., 1984). 
The non-significant change in systemic glutathione markers also demonstrates the 
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safe duration of at least 30 min limb occlusion, as previous research has 
associated prolonged limbed ischemia (3 hrs) with multiple organ dysfunction 
syndrome via circulating ROS and activated leukocytes (Yassin et al., 2002).    
The assessment of PC concentration in the blood following knee specific 
tourniquet mediated ischemia is a novel finding. In fact, the majority of studies 
assessing limb occlusion have evaluated PC concentrations in the localised tissue 
(Ozyurt et al., 2006; Avci et al., 2012; Ozkan et al., 2012). In contrast to the data 
provided here, previous studies assessing plasma PC concentrations following 
ischemia-reperfusion in other tissues (cardiac, intestinal) displayed a significant 
increase in plasma oxidised protein concentrations (Narayani et al., 2003). It could 
be speculated that different sampling sites (i.e. systemically or directly from the 
ischemic site) and varying experimental durations of ischemia-reperfusion utilised 
by Narayani et al. (2003) could account for the disparity in plasma PC 
concentrations in comparison to the current study. However, the authors failed to 
state this information, creating difficulties in producing valid comparisons to the 
work presented here.  
Furthermore, the stable concentrations of PC observed here (Table 4.1) are not 
surprising considering the lack of significant variation in the GSSG 
concentrations. Indeed, the simultaneous increase in both GSSG and PC 
concentrations has previously been noted following ischemia reperfusion in rat 
hindlimb (Grisotto et al., 2000). The ischemic bout promotes the formation of 
ROS (such as OH
•
, O2
-
) and ROS associated intermediates (H2O2) upon 
reperfusion, inducing cellular protein oxidation. GSH metabolises the ischemic 
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mediated H2O2, thus removing the intermediate in the chain reaction that 
synthesises the extremely reactive OH
•
, invariably forming GSSG and minimising 
protein damage (Mari et al., 2013). Thus, a fairly constant GSH/GSSG ratio 
indicates minimal disruption to the redox balance (Asensi et al., 1999), therefore, 
negligible protein oxidation would occur.  
5.2 Muscle HSP expression 
The blunting of the tourniquet induced response noted by the reduction in Hsp72 
displayed in both HYP and TOR in comparison to SHAM at 15PoT, also showed 
a large effect size (1.90 and 2.19, respectively) (Figure 4.2). Similar observations 
were noted by Bushell et al. (2002). The authors showed IPC did not stimulate an 
increase in skeletal muscle Hsp72, when a dramatic rise was observed in the 
control condition. Interestingly, the authors still witnessed protection in the IPC 
tissue following an ischemic insult, in spite of the stable Hsp72 concentrations, 
thus, indicating that perhaps HSP72 does not play a role in early preconditioning. 
Therefore, the blunted response observed in both TOR and HYP in comparison to 
SHAM would suggest a reduction in cellular stress from conditioning 
(Theodorakis et al., 1999) rather than an IPC mechanism.  
IPC acts in a biphasic pattern, with the early phase of protection being initiated 
immediately post preconditioning and lasting up to 3 hrs (Yang et al., 2010); 
while the delayed phase occurs 24 hrs following the stimulus, enduring for up to 
72 hrs (Hausenloy and Yellon, 2010). Previous research implicates adenosine as a 
key molecule in initiating early IPC (Liu et al., 1991). The ischemic environment 
leads to the degradation of AMP via 5’-nucleotidase (Kitakaze et al., 1995), 
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directly stimulating protein kinase C (PKC) (Carden and Granger, 2000). PKC has 
been proposed to act upon the mitochondrial potassium ATP (mKATP) channel and 
the mitochondrial permeability transition pore (mPTP), with the former inducing 
an influx of K
+
, further stimulating PKC (Sadat, 2009). The activation of PKC 
inhibits the mPTP, whilst also activating cytochrome C oxidase, further increasing 
cellular respiration, thus protecting the cell from excessive ROS (Sadat, 2009). 
Besides adenosine, bradykinin can also stimulate PKC indirectly through ERK 
and redox signalling, ultimately inducing PKC activation via ROS stimulation 
(Cohen et al., 2007).   
Although the mechanism described above explains the diminished tourniquet 
mediated stress in TOR, it does not directly provide evidence for the same Hsp72 
decrease noted in HYP. However, it has been previously stated that HPC acts 
through similar redox mechanisms as IPC (Zuo et al., 2013). In fact, this would be 
logical considering the increase in adenosine is produced via the degradation of 
AMP (Kitakaze et al., 1995) that has accumulated through the disturbance of 
aerobic respiration (Jennings and Reimer, 1991), which can be produced by both 
hypoxia and ischemia. This has been confirmed via pharmaceutical blockade of 
PKC, the mKATP channel and adenosine receptors, ultimately abolishing the 
protective effects of HPC in cardiomyocytes (Nojiri et al., 1999). Interestingly, 
the same study noted that nicorandil, a mKATP channel opener, which has 
previously been shown to induce HPC protection from IRI, did not bestow the 
same protection when PKC was inhibited, demonstrating that mKATP channel 
opening leads to PKC activation, which is in contrast to the activation mechanism 
of IPC. Therefore, the reduction in ischemic mediated stress observed in both 
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TOR and HYP in the present study (Figure 4.2) could be produced via the 
aforementioned mechanism.  
A significant increase in Hsp72 at 120PoT compared to PrT was noted in TOR 
(Figure 4.2). Although not in skeletal muscle, a similar rise in Hsp72 was cited in 
rabbit cardiac tissue 3 hrs following IPC (Tanaka et al., 1998). Previous research 
has described HSP72 as a major instigator in producing the delayed effects of IPC 
to afford protection for future insults (Lepore et al., 2000; Okubo et al., 2001; Li 
et al., 2003). Consequently, the sharp rise in Hsp72 at 120PoT displayed by TOR 
could potentially be explained by the delayed phase of IPC. However, the 
elevation in Hsp72 noted here is following the combination of both IPC and TKR 
specific tourniquet application, not just following IPC as mentioned by previous 
research (Tanaka et al., 1998; Li et al., 2003), hence it is not classical delayed 
IPC. Thus, it could be suggested that the rise in Hsp72 could merely be a result of 
oxidative stress from the TKR specific tourniquet application (Lepore et al., 
2001); nonetheless if this were the case, a similar increase would have been 
expected in SHAM (Figure 4.2). Therefore, it could be inferred that the presence 
of increased Hsp72 concentrations could be explained by the delayed 
preconditioning phenomenon from the IPC.   
The postponed protection afforded by IPC has been attributed to de novo synthesis 
of cytoprotective proteins such as HSPs, eNOS, cyclooxygenase-2 and MnSOD 
(Hausenloy and Yellon, 2010). The up-regulation of these proteins occurs through 
the activation of a multitude of transcription factors, stimulated by endogenous 
mediators including PKC, adenosine and tyrosine kinase (Heusch et al., 2008; Yin 
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et al., 2009). The synthesis of HSP70 is speculated to refold sub-lethal damaged 
proteins or diminish their interactions with viable proteins during the prolonged 
ischemia/reperfusion bout (Marber et al., 1993). This is further supported by 
evidence of infarct reduction in rabbit models overexpressing HSP72 (Okubo et 
al., 2001). In addition to providing cytoprotection, HSP70 has also been shown to 
mediate κ-opioid receptor stimulation, which are in part responsible for delayed 
IPC (Zhou et al., 2001). This may partly explain the increase in Hsp72 at 120PoT 
depicted in Figure 4.2.          
In contrary to the research that considers HSP72 crucial to delayed IPC, it has also 
been proposed that the occurrence of HSP72 24 hrs following IPC may in fact be 
a marker of delayed preconditioning, rather than the mechanism involved in 
providing protection (Pagliaro et al., 2001). Qian et al. (1999) demonstrated a 
marked increase in HSP72 24 hrs following IPC in rat myocardium, however, this 
rise did not induce protection in myocardial tissue. The authors concluded that the 
discrepancy could be a variation in species response to delayed preconditioning. 
Nevertheless, it has been proposed that PKC may also play a pivotal role in both 
phases of preconditioning, with the activation of PKC in the delayed phase 
governed by tyrosine kinase and NO, ultimately inducing further opening of the 
mKATP channel (Pagliaro et al., 2001). However, recent novel research has 
instigated the small non-coding microRNAs as another potential mechanism of 
delayed IPC (Yin et al., 2009). Yin and colleagues (2009) demonstrated that 
injection of microRNAs reduced the infarct size in murine hearts and up-regulated 
HSP70, eNOS and hypoxia induced factor -1α, possibly through post-
transcriptional regulation of injurious genes. The rise in Hsp72 noted in the 
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current research (Figure 4.2) could potentially be a precursor to delayed 
preconditioning; however the literature remains controversial regarding this 
hypothesis.  
Surprisingly, HYP did not display the dramatic rise in Hsp72 demonstrated by 
TOR at 120PoT. This is unexpected considering the evidence outlined above 
depicts that both HPC and IPC appear to share similar molecular mechanisms. 
However, it could be hypothesised that HYP demonstrated a severe reduction in 
oxidative stress during the TKR specific tourniquet application compared to TOR, 
thus leading to reduced HSP response via hypoxia induced Hsp72 down-
regulation (Oehler et al., 2000). Furthermore, the negligible elevation in Hsp72 at 
120PoT would also indicate the absence of HSP72 in inducing delayed 
preconditioning as aforementioned in HYP. This is in disagreement with previous 
literature, which has attributed HSP72 in producing the delayed preconditioning 
phase (Engelman et al., 1995). Nevertheless, the study by Engelman et al. (1995) 
displayed a rise in Hsp70 4 hrs following a prolonged hypoxic exposure post 
HPC, thus it could be speculated that the stable Hsp72 demonstrated here (Figure 
4.2) was merely a disparity in sampling time and may occur later than IPC. 
Interestingly, the same study did not find an increase in Hsp70 ensuing HPC prior 
to the sustained hypoxic insult. This is in line with the current study where no 
significant difference was observed between HYP and SHAM at PrT. It could be 
suggested that the absence of an increase in Hsp72 following HPC could 
potentially be via the inhibition of the kinase, mammalian target of rapamycin 
(mTOR). mTOR has been cited as a major kinase involved with crucial 
phosphorylation of HSF1 following dissociation from HSPs (Chou et al., 2012). 
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However, acute normobaric hypoxia has been demonstrated to inhibit mTOR 
function (D'Hulst et al., 2013), thus preventing HSF1 phosphorylation and further 
transcription of Hsp72. This mechanism may explain the stable concentrations of 
Hsp72 (Figure 4.2) observed in the current research.     
The present study did not show a change in muscle Hsp32 between any of the 
conditions (Figure 4.3). This is in disagreement with previous research showing 
that Hsp32 expression transiently increased following HPC (Berger et al., 2010) 
and greater protein expression succeeding IPC (Badhwar et al., 2004). It is 
postulated that the lack of variation in Hsp32 concentrations could be via Hsp32 
transcriptional repression during the hypoxic insult. Nakayama et al. (2000) 
established that heme oxygenase-1 (HSP32) is down-regulated in ECs during the 
hypoxic exposure. It has been postulated that the reduction in Hsp32 
concentrations could consequently reduce the large energy expenditure associated 
with heme degradation, preserving vital ATP stores (Nakayama et al., 2000). 
Additionally, the reduction in translation of de novo HSP32 during the hypoxic 
period would diminish the immediate production of CO, preventing its binding to 
oxygen sensing heme molecules, invariably disrupting their function (Shibahara, 
2003). Indeed, the transcription factor Bach-1 has been identified as a regulator of 
HSP32 (Ogawa et al., 2002). The presence of heme negatively affects Bach-1’s 
ability to repress HSP32 gene expression via DNA binding (Ogawa et al., 2002).  
The present data did not show a significant down-regulation of muscle Hsp32 
throughout the assessed time-points, nevertheless, this could possibly be due to 
the short hypoxic exposure (40 min hypoxia, 60 min recovery, 30 min ischemia) 
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experienced by the participants, thus resulting in the equalised Hsp32 
concentrations observed over the experimental period (Figure 4.3). It could also 
be speculated that the stable concentrations of Hsp32 may be a fibre type specific 
response. Type I muscle fibres have been shown to readily express HSP32 in 
comparison to a blunted response noted in type II fibres (Vesely et al., 1999). The 
lateral head of the gastrocnemius consists of equal proportions of both fibre types 
(Edgerton et al., 1975), therefore the response observed in the present study may 
only be proportional to the percentage of type II fibres in the muscle.                     
5.3 Application of results 
Recently, the use of IPC as non-pharmaceutical, non-invasive intervention has 
been cited to diminish postoperative pain following TKR surgery (Memtsoudis et 
al., 2010). Although the difference in pain noted by Memtsoudis and colleagues 
(2010) was not the main aim of the study, the simplicity of IPC allowed it to be 
performed during draping/surgical preparation ensuring no delay to 
commencement of surgery, thus, even a modest improvement in patient perceived 
pain should be seen as a positive and an advocate for the use of IPC as an addition 
during TKR surgery. The present study has also demonstrated that HPC provides 
similar protective effects to IPC against 30 min tourniquet mediated ischemia. In 
addition, the simplicity of the HPC protocol used here could also be undertaken 
during the pre-operative phase while the patient is still on the ward. The present 
HPC protocol has the added benefit of less staff involvement than IPC through 
redundancy of tourniquet inflation/deflation monitoring.  
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Furthermore, length of stay has been demonstrated to significantly decrease 
following IPC in comparison to control in TKR out-patients (Memtsoudis et al., 
2010). Although these results (reduction in pain and LOS) are promising, the 
study itself was not specifically designed to identify clinical outcomes; therefore 
further research in this area is warranted. The similar effects induced by protection 
bestowed from HPC and IPC in the current study could potentially reduce length 
of stay comparatively to Memtsoudis et al. (2010) through attenuation of muscular 
tissue damage mediated through tourniquet use. Thus, if this were confirmed in a 
study designed to solely address this entity, it could potentially have a large effect 
upon clinical practise in the future.          
5.4 Limitations  
Firstly, many antioxidants are procured naturally from the diet, all with varying 
half-lives, potentially influencing the antioxidant defence capacity of the 
individual (Powers et al., 2010a). Although every effort was made to minimise 
this (standardised evening, morning and afternoon meal), it is extremely 
challenging to control participants’ diet over a long period of time, while ensuring 
continued participation. Therefore, the lack of change in oxidative stress markers 
could have partly been due to dietary variation.  
Secondly, difficulties obtaining blood samples from the site of ischemia (i.e. the 
right calf) hindered the possibility of further inferences from this data. If samples 
were collected from the ischemic site, the data may have alluded to a greater 
insight into the potential link between the localised tissue and the systemic blood. 
Previous research (Karg et al., 1997; Garcia-de-la-Asuncion et al., 2012) has 
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shown disparity between markers at the systemic and localised sites, consequently 
the oxidative stress markers measured in the present study may not depict the full 
cascade of events.    
Finally, the duration of limb ischemia utilised in this study (30 min) is lower than 
commonly used during TKR surgery (mean ± SD; 79.9 ± 12.7 min (Chang et al., 
2012)). Therefore, it is expected that the oxidative stress would be greater during 
surgery thus the current model performed in the study is not completely 
ecologically valid.     
5.5 Conclusions 
Overall, systemic markers of oxidative stress did not change during the trial in any 
condition, thus producing a stable time course for redox (GSH, GSSG, TGH, 
GSH/GSSG, PC) and stress protein markers (Hsp72, Hsp32) following both 
preconditioning and TKR specific tourniquet application. In addition, HPC and 
IPC did not induce a marked reduction in the systemic oxidative stress measures 
compared with a control condition. However, the significant reduction in localised 
cellular stress noted in both TOR and HYP at 15PoT is encouraging. This 
provides further evidence for protection offered via IPC but also demonstrates the 
potential of HPC in diminishing cellular stress associated with TKR specific 
tourniquet application, although the precise mechanisms of action were not 
alluded to in this study. The diminished localised stress provides a rationale for 
the extension of this research into a clinical population to establish more 
clinically-relevant qualitative measures for patient’s perceived pain and levels of 
surgical success.    
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Finally, to conclude this thesis, it is appropriate to revisit the experimental aims 
described at the end of the literature review section. The aims are restated below 
and an appropriate answer has been provided.  
1) Quantify the time course for redox disturbances to the systemic and 
localised circulation via analysis of PC, GSH, GSSG and TGH, following 
hypoxic and ischemic preconditioning, in addition to 15 min and 2 hrs 
succeeding tourniquet mediated ischemia.  
- Systemic circulation concentrations of PC, GSH, GSSG and TGH did not 
significantly fluctuate from basal following any of the interventions 
(SHAM, HPC, and IPC) and TKR specific tourniquet application. 
Localised circulatory redox markers were not assessed due to problems 
with localised blood collection.      
2) Examine the time course for changes in Hsp72 and Hsp32 in localised 
skeletal muscle, in addition to localised and systemic leukocytes utilising 
the same time points as outlined in 1).  
- HPC and IPC displayed a blunted Hsp72 response in skeletal muscle in 
comparison to SHAM 15 min following tourniquet release. Additionally, 
IPC displayed sharp increase 2 hrs post tourniquet release. Tissue Hsp32 
and Systemic circulatory Hsp72 and Hsp32 did not show any alterations 
following tourniquet release.            
3) Evaluate the efficacy of both whole-body HPC and limb IPC based on the 
observed changes in 1) and 2) from TKR specific tourniquet application. 
- HPC and IPC displayed a blunted Hsp72 response in comparison to 
SHAM 15 min following tourniquet release in skeletal muscle. Therefore, 
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suggesting that both HPC and IPC provided cellular protection to 
tourniquet mediated oxidative in localised tissue.    
 
5.6 Recommendation for future research 
Completion of this thesis has generated several potential areas for future research, 
specifically, establishment of oxidative stress markers and cell viability in the 
localised muscle. Furthermore, the potential benefits of preconditioning should be 
confirmed within a small clinical population undergoing TKR to establish more 
clinically relevant measures (i.e. length of stay, Oxford Knee Score, patient 
perceived levels of pain). The following section will provide a brief summary of 
studies addressing these issues.                        
5.6.1 Determination of redox disturbance and cellular structure in muscle 
tissue following HPC in a TKR specific tourniquet application 
The confirmation of reduced cellular structural damage and minimised 
disturbance to muscle redox balance would provide empirical evidence to the 
effectiveness of HPC.  In addition to the markers utilised here (GSH/GSSG, PC) 
antioxidant enzymes (e.g. MnSOD) and assessment of cell viability would provide 
a greater representation of the biochemical events occurring in the localised tissue 
following tourniquet application. An additional muscle biopsy would be added at 
24 hrs post tourniquet removal to assess changes peak changes in MnSOD levels 
(Hoshida et al., 1993). Venous blood would also be obtained at biopsy sampling 
times from the femoral vein to measure redox disturbances and ROS via spin 
trapping (Villamena and Zweier, 2004) (Figure 5.1). The use of western blot 
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analysis and ELISA assay kits would confirm protein and thiol concentrations 
respectively.   
 
Figure 5.1: Schematic of proposed experimental design. The shaded and blocked 
areas represent HPC and tourniquet ischemia respectively.  
 
5.6.2 The feasibility and clinical relevance of HPC in TKR surgery - A small 
clinical trial  
The research would be performed in hospital and adhere to a standard operative 
day. Participants would be screened for inclusion criteria (bleeding disorders, 
immunocompromised, respiratory disorders etc.)  (Memtsoudis et al. 2013) and 
undergo the HPC intervention while on the ward before admittance to surgery. In 
addition, pain (Visual analogue scale), analgesia consumption and muscular blood 
oxygenation would also be assessed at baseline, 6, 24 and 48 hrs post-operation 
(Figure 5.2). Assessment of standard TKR success criteria (Oxford Knee Scores, 
physiotherapy milestones) would also be recorded. These data would test the 
feasibility of utilising HPC in a hospital environment and provide clinically 
relevant information to the effectiveness of the preconditioning succeeding 
surgery.  
Muscle biopsy 
Venous blood 
Muscle biopsy 
Venous blood 
Muscle biopsy 
Venous blood 
Muscle biopsy 
Venous blood 
Basal Post
- 
+2 hrs +24 hrs 
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Figure 5.2: Experimental design for the clinical trial. Shaded and blocked areas 
represent HPC and TKR surgery respectively. Upon admittance variables would 
be obtained and patients would be prepared for surgery prior to commencing 
HPC. Succeeding surgery all measures would be collected while the patient is on 
the ward.        
Basal +6 hrs +24 hrs +48 hrs 
Pain (visual analogue scale) 
Analgesic consumption 
Muscular blood oxygenation 
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Appendix A 
   
Abstinence Criteria 
     
                         
                         Participant ID 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 
Alchol (72 hours)                                                 
Caffeine (72 hours)                                                 
Hot bath/sauna (48 hours)                                                 
Antioxidants (30 days)                                                 
Beta Alanine (15 weeks)                                                 
Glutathione (4 weeks)                                                 
Creatine (30 days)                                                 
Residing at Altitude (3 months)                                                 
Hyperthermic environments (3 months)                                                 
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Appendix B 
 
Information Sheet 
                     
 
Department of Sport and Exercise Sciences                    
Bedford Campus  
Polhill Avenue 
Bedford 
MK41 9EA 
  
 
Dear Participant,  
 
   Thank you for showing an interest in participating in this novel research. 
Please read this information sheet carefully before deciding whether to participate. If 
you volunteer we thank you for your participation. If you decide not to take part there 
will be no disadvantage to you of any kind and we thank you for considering the 
request. 
 
What is the aim of the project?  
The purpose of the study is to establish whether a hypoxic (low O2 levels) exposure 
prior to knee surgery specific tourniquet application, provides protection against tissue 
damage within the subjected leg.   
 
What type of participant is required? 
Participants must be 18-35 years of age, male, and in good health.  
 
What will the participant be required to do? 
Participants will be required to attend the Sport Science Laboratories at the University 
of Bedfordshire’s Polhill Campus on 2 occasions. You will be required to wear shorts, 
and abstain from alcohol and caffeine for 72 hours prior to testing. In addition you will 
be required abstain from intensive exercise and thermal events (sauna/very hot baths 
(normal bath/shower temperatures are acceptable)). Further you will be required to 
abstain from antioxidants, beta-alanine, creatine and glutamine for 30 days, 15 weeks, 
30 days and 4 weeks respectively. Finally, please ensure you have not resided at altitude 
or hot environments for the previous 3 months. On the day of testing, please consume 
500 mL of water 1 hr prior to start of testing to ensure adequate hydration. 
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Prior to testing you should complete a medical questionnaire, a blood analysis 
participant screening form and informed consent form, to demonstrate that you are 
physically capable of participating and that you understand what you are taking part in 
and the reasons why.  
 
Baseline Testing 
Prior to experimental testing you will visit the University of Bedfordshire’s laboratories 
once for baseline testing. This visit will require you to have your blood pressure, height, 
weight and body composition measured via use of the bodpod for the later, which will 
last around 30-40 minutes. Following this you will be allocated either to control, sham, 
hypoxic, or ischaemic conditions. Although subjects will not be informed which 
condition they have been placed in. 
 
Testing Overview 
Control condition: 
Seated in a laboratory room for 40 mins. 
 
Sham Condition: 
Seated in a laboratory inhaling normal ambient air (20.9% O2) through a mask attached 
to the Hypoxicator for 40 mins  
 
Hypoxic Condition: 
Seated in a laboratory inhaling hypoxic air (14.5% O2) through a mask attached to the 
Hypoxicator for 40 mins. 
 
Ischaemic Condition: 
Seated in a laboratory and have a tourniquet placed around their non-dominant thigh. 
Followed by 4 compression and release cycles lasting 5 minutes each. The tourniquet 
will be inflated to 100 mmHg above resting systolic blood pressure. 
 
Experimental Trial 
All subjects will be required to attend the laboratories at 11:00 am on their day of 
testing. Upon arrival you will be required to provide a urinal sample to assess hydration 
status. If dehydrated, subjects will be asked to drink 500 ml of water. Participants will 
then be asked to sit on a massage couch, during which time, two cannulae will be placed 
in the antecubital region (lower arm) and the small sephinous vein (calf) by either a 
suitably trained affiliate of the University of Bedfordshire or experienced medical 
practitioner from Milton Keynes General Hospital (MKGH). Subjects will then be 
requested to sit and rest for 1 hour. A blood sample from both cannulae will be obtained 
to assess levels of fold change in heat shock protein (HSP) 72 and 32, in addition to 
determining protein and oxidative stress concentrations. 
 
Participants will then place, on to themselves, a heart rate (HR) monitor and an 
oximeter (on to the great toe of the non-dominant leg). Subjects will then undertake 
their allocated intervention as outline above. During this time HR and oxygen saturation 
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(OS) will be monitored. On completion, blood samples will be taken from both 
cannulae. Subjects will then be asked to sit and rest for 1 hour. 
 
Next you will be asked lay in a supine (on your back) position, and provide a muscle 
sample obtained from the lateral side of the gastrocnemius (calf), which will be obtained 
by an experienced medical practitioner from MKGH. In addition to muscle samples, 
blood will also be extracted from both cannulae at this point. A tourniquet will then 
placed upon your non-dominant leg and inflated to 100 mmHg above resting systolic 
pressure for 45 minutes. During this time your HR and OS will be measured. In addition 
to these, your thermal sensation (how hot/cold you feel) and pain (via a visual analogue 
pain scale) will be taken in consideration to your whole body and subjected leg. Once 
the elected time has elapsed, the tourniquet and oximeter will be removed and another 
muscle and blood sample will be obtained 15 min post removal of the tourniquet from 
the same regions as previously stated.  
 
Subjects will be required to return to have further blood and muscle samples taken 2 
hours post removal of the tourniquet. Upon completion HR monitor will be removed.    
 
What are the possible risks of taking part in the study?  
There will be a trained first aider in the immediate vicinity throughout all testing. 
During the muscle biopsy and blood sampling there is a slight risk of infection and you 
may experience a degree of discomfort. However, the risk of infection will be kept to a 
minimum through use of a designated clinical area and performed using sterile 
techniques. The level of discomfort during blood sampling will be minimised through 
the use of a trained phlebotomist (individual who takes blood samples) and during the 
muscle biopsy an orthopaedic surgeon will be performing the procedure.  
There is a potential risk of altitude sickness when exposed to oxygen levels of 14.5%. 
This risk is minimum and all researchers involved are aware of the symptoms. During 
the experimental trial you may experience some discomfort from the tourniquet, 
although once removed, this will subside. 
 
What if you decide you want to withdraw from the project? 
If, at any stage you wish to leave the project, then you can without given explanation. 
There will be no disadvantage to yourself should you wish to withdraw. 
 
What will happen to the data and information collected? 
Everyone that takes part in the study will receive their own results for the tests that they 
complete for your own personal development and understanding. All information and 
results collected will be remain anonymous and held securely at the University of 
Bedfordshire and will only be accessible by the project team. Results of this project may 
be published, but any data included will in no way be linked to any specific participant. 
Your anonymity will be preserved. 
 
What are the potential benefits of the study? 
The present study will determine whether hypoxic and ischaemic interventions reduce 
the amount of tissue damage sustained after tourniquet application. Consequentially, if 
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successful, may reduce time needed for rehabilitation inducing reductions in cost for 
hospitals and clinics. In addition participants will obtain a full body composition profile 
(% fat and lean mass) worth £50.  
 
Questions are always welcome and you should feel free to ask either myself, James 
Barrington, Dr Lee Taylor or an independent contact, Professor Angus Duncan at 
anytime. See details below for specific contact details. 
 
If you are interested in taking part in the project and would like to receive more details 
about the studies please send an email to either:  
  
James Barrington: 07734821427   Dr Lee Taylor 
Email: James.Barrington@beds.ac.uk  Email:Lee.Taylor@beds.ac.uk  
          
Department of Sport and Exercise Sciences,            Professor Angus Duncan 
University of Bedfordshire              Email:Angus.Duncan@beds.ac.uk 
Bedford Campus,  
Polhill Avenue, Bedford 
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Appendix C 
 
CONSENT FORM 
 
TO BE COMPLETED BY PARTICIPANT 
 
 
NAME:…………………………………………………(Participant) 
 
I have read the Information Sheet concerning this project and understand what it is 
about. All my further questions have been answered to my satisfaction. I understand that 
I am free to request further information at any stage. 
 
I know that: 
 
-  My participation in the project is entirely voluntary and I am free to  
   withdraw from the project at any time without disadvantage or prejudice.  
-  I will be required to attend testing in the sport and exercise science laboratories 
on 2 separate occasions to complete the project. 
 
-  As part of the study I will have to:  
 
 Undergo body composition measurements through use of the bodpod. 
 Have blood pressure measured. 
 Provide a urine sample for testing pretesting.   
 Have a cunnula placed in both antecubital region (inside of the arm) and in the 
small saphenous vein (back of the calf). 
 Have heart rate monitored throughout testing. 
 Have oxygen saturation levels measured throughout testing. 
 Be exposed to one of the four following interventions: 
 Normoxic environment (20.9% O2, 775 mmHg) at rest for 40 mins. 
 Hypoxic environment (14.5% O2, 775 mmHg) at rest for 40 mins. 
 4 cycles of 5 mins compression and 5 mins reperfusion from a tourniquet 
inflated to a 100 mmHg above resting systolic pressure placed on the 
thigh. 
 Control environment – seated in the laboratory at rest for 40 mins.  
 Undergo 45 mins of tourniquet compression inflated to a 100 mmHg above 
resting systolic pressure placed on the thigh.   
 Give an indication of pain and ratings of thermal sensation throughout testing. 
 Provide 10 blood samples and 3 skeletal muscle biopsies. 
 
-  I am aware of any risks that may be involved with the project. 
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-  All information and data collected will be held securely at the University 
indefinitely. The results of the study may be published but my anonymity will be 
preserved. 
 
Signed:………………………………… (Participant) Date: ……………… 
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Appendix D 
 
BLOOD ANALYSIS  
 
Please read the following: 
 
a. Are you suffering from any known active, serious infection? 
b. Have you had jaundice within the previous year? 
c. Have you ever had any form of hepatitis?  
d. Have you any reason to think you may be HIV positive? 
e. Have you ever been involved in intravenous drug use? 
f. Are you a haemophiliac? 
g. Is there any other reason you are aware of why taking blood might be  
    hazardous to your health?  
h. Is there any other reason you are aware of why taking your blood might be  
    hazardous to the health of the technician? 
 
 
Can you answer Yes to any of questions a-g?    Please tick your response in the box 
below: 
       
Yes   No  
 
 
 
Small samples of your blood (from finger or earlobe) will be taken in the manner 
outlined to you by the qualified laboratory technician. All relevant safety procedures 
will be strictly adhered to during all testing procedures (as specified in the Risk 
Assessment document available for inspection in the laboratory). 
 
  I declare that this information is correct, and is for the sole purpose of giving the  
  tester guidance as to my suitability for the test.  
 
    Name  ………………………………………  
 
   Signed  ………………………………………  
      
   Date  ……………………………………… 
 
  If there is any change in the circumstances outlined above, it is your responsibility to 
  tell the person administering the test immediately. 
 
 
The completed Medical Questionnaire (Par Q) and this Blood Sampling Form will be 
held in a locked filing cabinet in the Department of Sport and Exercise Science 
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laboratories at the University for a period of one-three years. After that time all 
documentation will be destroyed by shredding. 
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Appendix E 
 
General pre-test medical questionnaire 
 
To be completed by all subjects before participating in practical sessions. 
 
 
Name: ………………………………………………….  
 
Age:……………   Gender:  M    /    F 
 
1 Are you in good health?        Yes    /    No 
If no, please explain:      
 
2 Are you pregnant or have you given birth in the last 6 months?   Yes    /    No 
 
3 How would you  describe  your present level  of  moderate activity? 
 < once per month 
     once per month 
     2-3 times per week 
     4-5  times per week 
  > 5 times per week 
 
4 Have you suffered from a serious illness or accident?        Yes    /    No 
If yes, please give particulars: 
 
5 Are you recovering from an illness or operation?          Yes  /    No 
If yes, please give particulars: 
 
6 Do you suffer, or have you ever suffered from: 
Respiratory conditions (asthma, bronchitis, tuberculosis, other)?       Yes    /    No 
Diabetes?          Yes    /    No 
Epilepsy?          Yes    /    No 
High blood pressure?          Yes    /    No 
Heart conditions or circulation problems: 
(angina, high blood pressure, varicose vein, aneurysm, embolism, heart attack, other)?       
Do you have chest pains at any time?           Yes    /    No 
Do you suffer from fainting/blackouts/dizziness?               Yes    /    No 
Is there any history of heart disease in your family?           Yes    /    No 
 
7 Are you currently taking medication ?          Yes    /    No 
If yes, please give particulars: 
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8 Are you currently attending your GP for any condition or have you consulted your 
doctor in the last three months? If yes, please give particulars:       Yes    /    No  
    
 
9 Have you had to consult your doctor, or had hospital treatment within the last six 
months?               Yes    /    No 
 
10 Have you, or are you presently taking part in any other laboratory 
 experiment?              Yes    /    No 
 
PLEASE READ THE FOLLOWING CAREFULLY 
 
Persons will be considered unfit to do the experimental exercise task if they: 
 
have a fever, suffer from fainting spells or dizziness; 
have suspended training due to a joint or muscle injury; 
have a known history of medical disorders, i.e. high blood pressure, heart or 
lung disease;  
have had hyper/hypothermia, heat exhaustion, or any other heat or cold disorder; 
have anaphylactic shock symptoms to needles, probes or other medical-type 
equipment.  
have chronic or acute symptoms of gastrointestinal bacterial infections (e.g. 
Dysentery, Salmonella) 
have a history of infectious diseases (e.g. HIV, Hepatitis B); and, if appropriate 
to the study design, have a known history of rectal bleeding, anal fissures, 
haemorrhoids, or any other condition of the rectum; 
 
DECLARATION 
I hereby volunteer to be a subject in experiments/investigations during the period of  
20___. 
 
My replies to the above questions are correct to the best of my belief and I understand 
that they will be treated with the strictest confidence. The experimenter has explained to 
my satisfaction the purpose of the experiment and possible risks involved. 
 
I understand that I may withdraw from the experiment at any time and that I am under 
no obligation to give reasons for withdrawal or to attend again for experimentation. 
 
Furthermore, if I am a student, I am aware that taking part or not taking part in this 
experiment, will neither be detrimental to, or further my position as a student. 
 
I undertake to obey the laboratory/study regulations and the instructions of the 
experimenter regarding safety, subject only to my right to withdraw declared above. 
 
Name of subject (please print) 
________________________________________________ 
135 
 
 
Signature of Subject __________________________________             Date:  
 
Name of Experimenter (please 
print)____________________________________________ 
 
Signature of Experimenter  _____________________________              Date:  
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Appendix F 
Muscle Biopsy Procedure 
The biopsy site should then be cleaned using an alcohol spray or wipe. 
The skin, adipose tissue and skeletal muscle fascia should then be anaesthetised using 
5cm3 of 1% lidocaine being injected into the biopsy site in 2.5 cm3 doses at 45° 
proximal and 45° distal to the biopsy site respectively. Allow 3-5 min for anaesthetic to 
take effect. 
Apply chlorhexodine to skin in preparation to biopsy site and surrounding leg. 
A #11 scalpel should then be used to make a 4-5mm longitudinal incision. 
The “non biopsy hand” should then grip muscle on superior side of the leg. The biopsy 
needle should be inserted into incision at an angle perpendicular to skin surface. Once 
resistance has been met, flatten the angle of the needle to 45°. Then press the biopsy 
gun button and remove needle quickly. 
Allow assistant to remove tissue from needle (to be snap frozen in liquid nitrogen) 
whilst applying pressure to the wound with sterile gauze. 
Any subsequent passes (repeat of above) should be lateral to the previous pass. 
Following the last pass, firm pressure should be applied for up to 5 mins (or until 
bleeding stops). 
Apply Steristrip (2 cm length) across the incision and then a dressing. Clean leg before 
participant leaves the room. 
Once participant leaves room, spray bed clean and wipe down. 
 
 
 
